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INTRODUCTION 
Colostrum-acquired immunity is the primary source of pas­
sively acquired antibodies in the baby pig (Speer (1957), 
Brambell (1958)). Intact antibodies from the colostrum in­
gested by the baby pig are absorbed from the intestinal tract 
for only a matter of hours after birth and any further attempt 
to increase the level of serum antibodies by oral administra­
tion of antibodies has met with little success (Speer (1957)). 
In years past, the common practice was to allow pigs to 
nurse their dams until they were approximately 8 weeks old. 
However, more recently, the routine practice of early weaning 
baby pigs at 2 to 3 weeks of age has become quite common. In 
weaning at this early age a certain amount of stress is 
brought upon the baby pig. The baby pig is offered dry feed 
and it usually takes 3 or 4 days for a baby pig to develop 
proper eating habits. Even if the dry feed is nutritionally 
equivalent to sow's milk, these few days that the baby pig 
is not eating properly are sufficient to create a great 
metabolic disturbance in the baby pig. 
It is during and immediately after this period of stress 
that the baby pig would seem to offer the least resistance to 
infection. In addition, organisms that are ordinarily clas­
sified as non-pathogenic may suddenly overwhelm the baby pig. 
These factors combined may easily result in a "stunted" pig 
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or in some cases even death. The baby pig may fight off these 
infections normally by use of colostrum-acquired antibodies 
or by actively producing antibodies for each specific organ­
ism. 
Various studies have been made concerning passively 
acquired immunity and active antibody production in the young 
of several species. However, few investigations have been 
made concerning colostrum-acquired immunity and active anti­
body production in baby pigs. 
The study reported herein was conceived and initiated to 
investigate the normal life of colostrum-acquired immunity 
in baby pigs, the active antibody production of baby pigs 
weaned at two weeks of age, the effect of colostrum-acquired 
immunity on active antibody production, and other immuno­
logical factors in resistance to infection. 
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LITERATURE REVIEW 
Route of Antibody Absorption in Baby Pigs 
In a study on swine abortion Hayes (1921) noted that the 
offspring of sows infected with Bacterium abortus were born 
without agglutinins, but agglutinins were present in the serum 
of the offspring soon after nursing. The colostrum was rich 
in agglutinins and complement-fixing antibodies. This is 
apparently the first demonstration that baby pigs receive 
antibodies passively from the colostrum and not via the 
placenta. Nelson (1932) used vaccinia as an immunizing agent 
to study the route of maternal transmission of antibodies in 
swine and made observations in agreement with Hayes (1921). 
Sows were vaccinated immediately prior to and shortly after 
breeding. After parturition some of the baby pigs were 
allowed to nurse their dams, and some were not permitted to 
nurse their dams and fed a. mixture of dried cow's milk and 
normal swine serum. Seven days subsequent to parturition the 
pigs were vaccinated with the vaccinia virus and observed 
for a minimum of 10 days. The pigs suckled by immune dams 
showed no vaccinia reaction; however, the pigs handfed the 
cow's milk and swine serum mixture responded to the virus 
with the formation of skin vesicles typical for the infection. 
Baby pigs nursing non-immune dams also showed skin vesicles 
when vaccinated. Nelson (1932) concluded that the porcine 
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placenta was Impermeable to any appreciable amount of protec­
tive substances, and that the function of immunity transfer 
was assumed by the colostrum. Earle (1935) studied the pro­
teins of the blood serum of baby pigs. Using the sodium sul­
fate precipitation method of Howe (1921), Earle ( 1935) arrived 
at the same conclusions with baby pigs that Howe (1921) did 
with the new-born calf. The baby pig was born with little 
or no euglobulin, but after receiving colostrum the blood 
did contain a large amount of euglobulin. 
Though Deutsch (1947) did not study the transfer of 
immunity from dam to offspring, electrophoretic analyses, 
using the Tiselius apparatus, revealed a slow-moving component 
in sow colostrum whey fraction accounting for the largest 
share of the protein present. This fraction, which is asso­
ciated with the immune globulins and which has a mobility 
nearly the same as gamma globulin, decreased rapidly a few 
days post-partum. Foster et al. (1951) noted similar changes. 
In one of their samples obtained immediately post-partum, the 
slow-moving component accounted for 70 percent of the whey 
protein. Their study also included data on baby pigs. The 
gamma globulin content in the pigs' plasma before nursing was 
as low as 2.7 percent although it rose to as high as 40 per­
cent at 24 hours post-partum. When baby pigs were removed 
from their dams at birth, Barrick et al. (1954) were unable 
to detect any gamma globulin in the blood serum 24 hours 
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later. The blood serums of baby pigs nursing their dams con­
tained 41 to 46 percent gamma globulin 24 hours post-partum. 
Several researchers concerned with specific disease 
entities have shown that little if any placental transfer of 
immune bodies takes place in utero in swine. Young and Under-
dahl (1949) detected no hemagglutination inhibition antibodies 
against swine influenza in 37 baby pigs at birth. Thirteen 
pigs did show low serum titers. They felt that these low 
serum titers were due to naturally-occurring inhibiting sub­
stances, and concluded that placental transfer of swine influ­
enza virus antibodies does not occur in swine. Significant 
titers were detected in baby pigs' blood serum samples within 
30 minutes after they had begun to nurse. Later, Young and 
Underdahl (1950) tested for both hemagglutination inhibition 
and neutralizing antibodies against swine influenza virus in 
baby pigs farrowed by sows challenged with the disease, and 
arrived at the same conclusion. Both hemagglutination inhibi­
tion and neutralizing antibodies were present in the colostrum 
of dams as shown by the high titers. In his studies on swine 
brucellosis, Hoerlein (1952) was unable to isolate Brucella 
melltensls from any of the baby pigs farrowed by infected 
sows. The pigs showed no agglutination titer at birth, but a 
maximum titer was reached in a matter of hours after receiving 
colostrum from their dams. 
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In his study on the length of time that the baby pig can 
absorb intact antibodies, Speer (1957) observed that baby 
pigs are born virtually free of antibodies, but obtain sig­
nificant amounts upon the first ingestion of colostrum from 
sows hyperimmunized with Escherichia coll » He also observed 
that pigs immediately post-partum could absorb nearly all of 
the antibodies intact. The ability of the baby pig to absorb 
antibodies intact decreased 50 percent every 3.06 hours from 
immediately post-partum to 24 hours of age. 
It is possible to raise baby pigs that have not received 
colostrum, but for any degree of success it has been necessary 
to rear them in isolation units under germ free conditions 
(Young and Underdahl (1953), Young et al. (1955), Shuman et 
al. (1956), VJhit eh air and Thompson (1956) ). 
Persistence of Passively Acquired Immune Globulins 
Following the ingestion of colostrum by newborn domestic 
animals, a globulin of low mobility appears in the blood and 
increases rapidly in concentration. This fraction with its 
immune bodies gives the young animal protection during the 
interim from birth until the animal's own antibody synthesiz­
ing mechanism becomes functional. Jameson et al. (1942) noted 
that the high concentration of gamma globulin present shortly 
after birth in calves decreased through the nursing period. 
McDiarmid (1946) followed the disappearance of colostral-
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derived Brucella abortus agglutinins in calves. The dis­
appearance of agglutinins followed a logarithmic curve. The 
length of time during which agglutinins persisted varied from 
a few days to a few months. The persistence depended to a 
large extent on the titer of the colostrum. Smith and Holm 
(1948) followed the disappearance of specific antibody as well 
as the change in the slow-moving, colostral-derived protein 
component in the calf. The half-life for Hemophilus pertussis 
and vaccinia virus antibodies was approximately 50 days, and 
the half-life for diphtheria antitoxin was about 16 days. The 
estimation of the half-life of the blood serum slow-moving 
componentj using the Tiselius apparatus, was 20 days. 
McCarthy and McDougall (1953) observed in lambs that 
high titers of Salmonella typhosa antibodies acquired soon 
after birth fell to low values 5 or 6 weeks later. 
Bangharn and Terry ( 1957) fed young rats adult rat serum 
labelled with radioactive iodine, and estimated the 
half-life of the selectively absorbed gamma, globulin at 5.2 
days. 
Young and Underdahl (1949, 1950) studied the longevity 
of passively-conferred hemagglutination inhibition antibodies 
in the baby pig. A gradual decrease in titer took place from 
a few days after birth to 8 weeks of age. Foster et al. 
(1951) studied the composition of baby pig plasma from birth 
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to 8 weeks of age. A decided decrease in the gamma globulin 
fraction occurred between the first day after birth and 3 
weeks of age. There was a slight increase in gamma globulin 
between 3 and 8 weeks of age. No determinations were made 
between these ages. 
Schoenheliner et al. (1942) and Heidelberger et al. ( 1942) 
studied the problem of persistence of antibodies both in pas-
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sively and actively immunized rabbits. Using N labelled 
amino acids as a tracer, the estimated half-life of an anti­
body molecule was about 2 weeks in actively immunized rabbits, 
but was only approximately 36 hours for the rabbits passively 
immunized with homologous pneumococcus Type I antiserum. In 
a rabbit, simultaneously actively and passively immunized, 
nitrogen uptake was found in the actively-produced antibody, 
while none was present in the passively acquired antibody. 
Wiener (1951) used a factor to allow for the dilution 
resulting from increased body weight in babies to measure the 
half-life of Rh antibodies. The Rh antibody half-life deter­
mined from the logarithmic regression line was approximately 
30 days. The author reported that a gamma globulin maximum 
was present at birth, and that this fraction diminished to 
its lowest point at 3 months of age. 
Barr et al. (1949) studied the disappearance of diph­
theria antitoxin in babies. The logarithmic regression line 
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showed a 50 percent loss every 4.5 weeks in diphtheria anti­
toxin concentration. Bulloch (1898) administered diphtheria 
antitoxin to a donkey and estimated the half-life to be about 
35-40 days. 
Active Antibody Production in Young Animals 
Famulener (1912) was able to produce only a slight immune 
reaction in kids injected subcutaneously with sheep erythro­
cytes at birth, 10 days, end at 18 days of age. Freund (192?) 
also was able to show only a slight Immune reaction in young 
guinea pigs experimentally Infected with Bacillus tuberculosis. 
Despite the presence of gross lesions of tuberculosis in the 
regional lymph nodes and in the spleen, dermal injections of 
watery extracts of B. tuberculosis showed only slight skin 
reaction. The adult mothers of guinea pigs infected under 
the same conditions when injected with the same watery ex­
tracts of B. tuberculosis showed marked redness, edema, and 
necrosis at the site of the injection. 
Freund (1330) immunized ten 1 to 2 day old rabbits with 
a bouillon culture of Bacillus typhosa. The rabbits were 
bled at 6 to 8 days of age at which time they showed traces 
of agglutinins up to the 1:10 dilution. In six other young 
rabbits 1 to 2 days of age Freund (1930) injected 0.25 ml. 
of sheep erythrocytes subcutaneously and bled them 5 to 6 
days later. The young rabbits Immunized with sheep erythro-
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eytes showed hemolysin titers as high as the 1:40 dilution, 
whereas their littermate controls showed hemolysin titers up 
to the 1:20 dilution. Egg white precipitation tests on young 
rabbits, injected at 2 days of age and every 4 to 5 days until 
2? days of age with 0.5 ml. of a 1:2 egg white dilution, were 
evident in traces up to the 1:100 dilution. 
From these studies, Freund (1930) concluded that young 
animals are very poor antibody producers. Baumgartner (1934, 
1937) reached similar conclusions. 
Overman (1954) studied the antibody response of suckling 
mice to mumps virus from birth to weaning. Litters of mice 
1, 5, 7, 10, 14, 21, and 28 days of age were inoculated intra-
peritoneally with mumps virus vaccine. At intervals of 2, 4, 
7, 9, 12, 18, 21, and 28 days after inoculation some of the 
animals in each group were bled for serological studies. No 
antibody response was detectable in mice inoculated up to 5 
days of age. A transitory antibody response was shown in the 
5 and 7 day old mice, but it was not maintained. When the 
mice reached an age of 14 days, an antibody response that 
compared favorably with that of older animals was found. The 
effect of a booster Injection was noted particularly in the 
5 and 7 day old groups which had previously exhibited a 
transitory response to the antigen. The booster injection 
was given 28 days after the initial injection. It was shown 
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that the booster Injection produced a significantly greater 
immune response in the 5 and ? day old groups than that of 
the younger mice. In this study Overman (1954) considered 20 
day old mice to be adults and the 14 day old mice produced 
an immune response equal to that of the adults. 
Sako (1947) studied pertussis Immunization in young in­
fants. He found that following immunization, agglutinins to 
pertussis reached a plateau in 2 to 4 months and remained at 
that level practically unchanged for 3 years. Thus, contrary 
to popular opinion, young infants were able to produce anti­
bodies to pertussis immunization. In the immunization of 
these young infants Sako (194?) used alum precipitated antigen 
to maintain prolonged antigenic stimulation. 
di Sant1Agnese (1950) studied simultaneous immunization 
of new-born infants against diphtheria, tetanus and pertussis. 
In his study, the material chosen for inoculation was a triple 
combined vaccine prepared by Gutter- Laboratories called 11 Al-
hydrox". In the material, 20 billion Hemophilus pertussis 
organisms per ml. are added to aluminum hydroxide adsorbed 
tetanus and diphtheria toxoids. One hundred and ninety-eight 
full term infants were studied. Three deep subcutaneous or 
intramuscular injections were given at monthly intervals. The 
first injection of 0.5 ml. at the age of 1 week, the second 
of 1.0 ml. at 5 weeks, and the third also of 1 ml. at 9 weeks 
of age. By the age of 9 weeks, a total of 2.5 ml. of the 
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vaccine containing 50 billion H. pertussis organisms had been 
administered. At the age of 13 weeks, 1 month after the 
administration of the three injections of "Alhydrox", only 
30 percent of 125 patients examined had no agglutinins to 
pertussis; 54.4 percent had a titer of 1:400 or higher. 
These figures show that the great majority of new-born in­
fants produce antibodies against H. pertussis after prophy­
lactic inoculation. At the age of 13 weeks all of the 128 
patients examined had more than the "protective" titer of 
tetanus antitoxin of 0.1 unit per ml., and 92 percent of these 
had very high titers of antitoxin, more than 1.0 unit per ml. 
of serum. At the age of 13 weeks, 84.6 percent of 123 infants 
had a "protective" titer of diphtheria antitoxin. Sauer et 
al. (1944), Sako et al. (1945), Bell (1948) and Sauer and 
Tucker (1950) made similar observations on the ability of in­
fants of comparable ege to produce antibodies immunized with 
similar antigens, di Sant1Agnese (1950) also compared the 
above mentioned routine with the same routine carried out with 
older infants beginning at 6 months of age. Pertussis agglu­
tinins and diphtheria antitoxin units were at least 100 per­
cent higher in the older group of infants, whereas the 
tetanus antitoxin units were very similar in the two age 
groups. 
Cooke (1948) administered combined diphtheria and 
tetanus toxoids to infants from 1 to 14 months of age. The 
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response to tetanus toxoid showed no significant relation to 
age; the infants under 3 months doing as well as the older 
groups. With diphtheria toxoid this was iwt the case, for, 
when the younger infants were sorted in accordance with the 
presence or absence of maternally transmitted diphtheria 
antitoxin, it was found that those without inherited anti­
toxin responded well to the diphtheria antigen, whereas those 
with 0.03 unit of antitoxin or more responded relatively 
poorly. Similar findings have been made by Butler et al. 
(i960) and Barr and G-lenny (1954). 
Ogborn ejt al. (1952a) studied the serum antibody titers 
in 40 infants of various ages to diphtheria toxoid injections. 
The age groups tested included infants under 2 weeks of age, 
1 month, 2 to 4 months and 6 month old infants. Blood serum 
samples were obtained as nearly similarly as possible at 1 
and 2 weeks, 1, 2, 3, or 4, and 6 months after immunization. 
The differences obtained in response showed that infants 2 
weeks of age were poorer antibody producers than those 1 month 
of age, and a difference between those of 1 month and 2 months 
of age was shown to be statistically significant (P = 0.05 or 
less). The differences between 2 to 4 months and those 6 
months of age were not statistically significant. 
Greenberg and Fleming (1950) studied the effect of 
inherited antibodies on the active immunization of infants. 
They stated that active immunization of infants 3 to 4 months 
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of age against diphtheria, pertussis and tetanus was found 
to be a sound procedure. The presence of inherited antibody 
(diphtheria antitoxin) had some effect in depressing the re­
sponse to diphtheria toxoid, but was not great enough to 
prevent satisfactory immunization in any of the infants. 
Response to tetanus toxoid and pertussis vaccine was found 
to be satisfactory. Greenberg and Fleming (1951) were con­
cerned with the level of immunity present in the above group 
one year after Immunization. In the original study (Green­
berg and Fleming (1950)) 74 infants with no inherited diph­
theria antitoxin and 31 with inherited antitoxin were used. 
One year later blood samples were obtained from 27 of the 
children with no inherited diphtheria antitoxin and 13 of 
the children with inherited diphtheria antitoxin. One month 
after immunization the 31 children possessing no inherited 
antibodies showed an average titer of 0.96 unit diphtheria 
antitoxin per ml. of blood. One year later the average was 
0.5 unit of diphtheria antitoxin per ml. of blood. For the 
13 children with inherited antibodies, the titer was 0.37 
unit of diphtheria antitoxin per ml. of blood and 1 year 
later the titer was 0.47 unit of diphtheria antitoxin. With 
one exception the titer was considered satisfactory for 
diphtheria antitoxin. The conclusion reached by Greenberg 
and Fleming (1951) was that the presence of inherited anti­
bodies did not prevent an adequate response to a good 
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antigen, but simply delayed it—a finding like that reported 
earlier by Vahlquist et al. (1948). 
Vahlquist and Nordbring (1952) and Danois et al. (1953) 
have measured the antibody response on premature infants and 
have found that it did not materially differ from that of 
full term infants. 
Osborn et al. (1952b) investigated the interference with 
active immunization by passive transplacental circulating 
antibody. Twenty-three infants were immunized under 2 weeks 
of age, 1 month, and between 2 and 6 months of age with diph­
theria toxoid. All of the infants showed circulating diph­
theria antitoxin ranging from 0.003 to 0.5 units per ml. of 
serum. It was found that when the passively acquired cir­
culating antibody was low, there wes no interference with 
active immunization as measured by antibody titers. The 
formation of circulating antibodies was depressed in infants 
with a high titer of passively acquired diphtheria antitoxin. 
Staub and Boguth (1956) found that pigs reared artifi­
cially for the first 3 days on a diet free from globulin show 
no gamma-globulin in their serum, but an increasing amount 
appears from the second week. Pigs given free access to 
colostrum and those given colostrum for only half a day show 
antibodies in their serum 5 to 6 weeks after parenteral intro­
duction of a bacterial antigen. In the serum of pigs reared 
entirely without sow1s milk, antibodies are first demonstrated 
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in the tenth week. Pigs receiving no colostrum for 3 days 
after birth and then suckled by the sow, show antibodies at 
5 weeks, the same time as those which suckled the sow from 
birth. 
Hoerlein (1957) studied the antibody response of baby 
pigs deprived of colostrum, and receiving normal colostrum 
when inoculated with Brucella abortus bacterin and sheep 
erythrocytes. The colostrum-deprived baby pigs were inocu­
lated with the antigens at from 3 to 8 weeks of age. No 
measurable antibody response was observed in pigs after the 
first inoculation of Brucella abortus, but most of them showed 
a definite response to the second inoculation given 3 weeks 
after the initial inoculation. The pigs were then 6 to 11 
weeks old. Approximately half of the pigs had a measurable 
agglutination titer 4 days after the second inoculation. 
Similar results were obtained from pigs inoculated with sheep 
erythrocytes. Ninety percent of the pigs receiving normal 
colostrum produced antibodies to Brucella abortus bacterin 4 
days after the inoculation at 3 weeks of age. A higher titer 
was observed in these pigs, receiving normal colostrum, after 
the second inoculation 3 weeks later. Severe anaphylactic 
shock was common Immediately following the second inoculation. 
Again, the response to inoculations of sheep erythrocytes 
was similar to the response obtained with the bacterin. 
Hoerlein (1957) further observed that pigs receiving 
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colostrum containing antibodies to Brucella abortus, show a. 
response to the bacterin much below that of the pigs receiving 
normal colostrum. 
Enhancement of General Disease Resistance 
Klein (1893) first observed that the intraperitoneal or 
subcutaneous injection of various killed bacteria prior to the 
administration of lethal doses of cholera organisms protected 
experimental animals. The next year Issaeff (1894) and 
Pfeiffer and Issaeff (1894) protected guinea pigs from lethal 
doses of cholera by a previous intraperitoneal injection of 
broth, peptone or urine. They observed a marked leucocytosis. 
in the body cavity at the time of challenge and attributed the 
increased resistance of treated animals to the release of 
bactericidal material from the leucocytes. Ledingham and 
Bulloch (1906) and Bedson (1915) found that the intravenous 
injection of autolyzed bacteria was followed within 2 hours 
by a marked increase in serum opsonic activity and leukocy­
tosis. The increased opsonic activity was nonspecific, was 
destroyed at 56° C. and disappeared after 24 hours. Hiss 
(1908) and Hiss and Zinsser (1908) observed that intraperi­
toneal injections of leucocyte extracts protected animals 
against subsequent infections with both gram positive and 
gram negative bacteria. They reported a marked leucocyte 
infiltration in protected animals and found that protection 
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was manifested in either intraperitoneal or septicemic infec­
tions. VJright ( 1931) observed increased bactericidal and 
phagocytic activities in the serum of animals injected pre­
viously with gram positive bacterial vaccines. The addition 
of these vaccines to normal serum in vitro also brought about 
an increased killing power. 
Heidelberger and co-workers in four studies (1946, 1947, 
1948 and 1949) have shown that subcutaneous injection of about 
50 micrograms each of two to six type-specific polysaccharides 
of pneumococcus into human subjects is followed by the appear­
ance, in most instances, of type-specific antibodies which 
reach peak levels in 2 to 6 weeks, continue at these levels 
for 5 to 8 months and then slowly decrease. Secondary in­
jections of the polysaccharides were not followed by the 
secondary increases in antibody content so characteristic of 
the antigenic effect of toxoids and many other antigens. 
Heidelberger et. al. ( 1950) studied the antibody levels of 
subjects injected, 3, 5 to 6, or 8 years previously with 
type-specific pneumococcal polysaccharides. These subjects 
showed measurable and sometimes relatively high antibody 
levels when their serums were analyzed after the periods indi­
cated. In instances in which an antibody had disappeared or 
remained only in small quantity, re-injection of the homo­
logous polysaccharide usually caused antibodies to reappear 
or to increase, although rarely to the original maximum. 
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Heidelberger et al. (1951) demonstrated that the pneumococcal 
type-specific polysaccharides contained no prosthetic group• 
The specific polysaccharide, with only 0.05 percent of nitro­
gen and 0.01 percent of phosphorus, still showed, after re­
peated precipitation, almost maximal expected antigenicity 
in man. Human anti-dextran was shown by Maurer (1953) to 
parallel pneumococcal anticarbohydrate in its persistence 
during the first 13 months following immunization. Allen and 
Kabat (1958) demonstrated similar antibody responses to blood 
group substances, dextran and levan. In addition to these 
similarities they reported that the antibody levels showed a 
decline of one-third to two-thirds of the peak values over a 
period of 3 years with the subsequent maintenance of these 
levels for additional periods of 1 to 9 years. 
Pi Heme r et al. ( 1954) originally described properdin 
(Latin, to destroy) as a heat labile euglobulin with a molec-
^weight—of—approximately—1^8——Lt—i-s—p-re-S-BP.-t—i-n-^?,o-r=-
mal human serum at a level of about 0.03 percent of the total 
serum proteins. It is not found in colostrum, milk or leuco­
cyte extracts. It requires the presence of complement and 
magnesium ions to exhibit bactericidal action against gram 
negative bacteria and inhibition of certain viruses. Pillemer 
et al. (1955) discovered that serum properdin formed complexes 
with a yeast component, zymosan, described by Pillemer and 
Ecker (1941), bacterial products, large branched polysaccha-
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rides and charcoal between the temperatures of 10 to 20° C., 
enabling its removal from serum without destruction of specif­
ic hemolytic complement. The original procedure for the prep­
aration of zymosan is presented in Appendix F. 
Landy and Pillemer (1956a) injected small amounts of 
purified lipopolysaccharide into mice and observed a transient 
increase in serum properdin levels within 12 hours. If mice 
were treated with small amounts of lipopolysaccharide 24 
hours prior to challenge with certain gram negative bacteria 
they were protected, whereas control mice showed decreased 
serum properdin levels and death. Rowley (1955) had pre­
viously shown this protective effect with prior injections 
of cell walls of Escherichia coll. Rowley (1955) noted an 
immediate highly susceptible state within 2 hours after in­
jection of the cell walls but an increased resistance if 
challenge doses were administered 24 hours later, Landy and 
Pillemer (1956b) correlated the maintenance of, or increase 
in, serum properdin levels with increased resistance of mice 
to challenge doses of gram negative bacteria. 
Pillemer and Ross (1955) studied the alterations in serum 
properdin levels following injections of zymosan in mice. 
They demonstrated an increased in serum properdin levels in 
mice 3 days after injecting 5 mg. per kg. of zymosan per kg. 
of body weight. Injections of 25 mg. of zymosan per kg. of 
body weight had little effect on the serum properdin levels of 
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however Injections of 125 rag. per kg. depressed the serum 
properdin levels from the original level after the same 
period. 
Ross (1958a) studied the relationships of properdin and 
infection. When he injected zymosan intravenously in mice at 
5 mg. per kg., 25 mg. per kg., and 125 mg. per kg., he found 
that in 5 minutes following the injection of zymosan, serum 
properdin levels were 50 percent of the original level after 
a dose of either 5 or 25 mg. per kg., and 16 percent after 
a dose of 125 mg. per kg. These titers persisted at their 
respective lowered levels up to 4 hours. Between 4 and 24 
hours following the injection of zymosan, serum properdin 
levels returned to 100 percent of original titers after a 
dose of 5 mg. per kg., 50 percent after 25 mg., and 25 per­
cent after 125 mg. per kg. Seventy-two hours following the 
administration of zymosan, serum properdin levels were 200 
percent of the original titers after 5 and 25 mg., and 50 
percent after 125 mg. Between 3 and 10 days after the intro­
duction of 5 and 25 mg. of zymosan, serum properdin levels 
were maintained at 200 percent of the original titers, while 
after 125 mg. the serum titer rose only to 75 percent of the 
original titer. At 12 days after the administration of 5 mg., 
the serum titer had fallen to 150 percent, end after 25 mg. 
the serum titer was 100 percent of the original level. 
In another experiment, Ross (1958a) injected mice with 
0.1 mg. (25 mg. per kg.) and 1.5 mg. (125 mg. per kg.) per 
mouse and later challenged the mice with Klebsiella pneu­
moniae . Control mice inoculated with 15 or 75 K. pneumoniae 
organisms had survival rates of 8 in 15, and 4 in 15, respec­
tively. Of the mice infected with 15 organisms at 4, 8, or 
12 weeks following preparation with 0.1 mg. of zymosan there 
were survival rates of 14 in 14, 8 in 8, and 6 in 8, respec­
tively. With mice prepared with 1.5 mg. of zymosan 1 or 4 
weeks before infection, the survival rates were 12 in 12, and 
6 in 6, against a challenge of 15 organisms. Against a 
challenge of 75 organisms, mice prepared with 0.1 mg. of 
zymosan 4, 8, or 12 weeks before infection, yielded 9 sur­
vivors in 14, 4 in 9, and 5 in 9. Bacterial challenge with 
75 organisms in mice given 1.5 mg. of zymosan 1 or 4 weeks 
previously yielded 13 survivors in 13, and 5 in 6. 
Kiser e_t al. (1956) showed that the pretreatment of mice 
with a 3 mg. dose of zymosan 24 to 48 hours prior to inocula­
tion with live organisms increased their resistance to Klebsi­
ella pneumoniae AD, Streptococcus pyogenes C203, Proteus 
vulgaris OX-19, Pseudomonas fluoresceins Ps2097, Micrococcus 
pyogenes var. aureus NY-104 and Bacillus anthracls 20S, and 
Pasteurella multocida P-652 in chicks. They were not able to 
show any effect on an infection with Diploooccus pneumoniae 
IR type 1 or Candida albicans in mice. In addition to 
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zymosan, Kiser et al. (1956) have shown that malucidin, 
mucin, some native dextrans, polysaccharides from types 12, 
14, 18, and 19 pneumococcl, polysaccharides from E. coll and 
a Pseudomonas species given at various times before infection 
increase resistance to infection to K. pneumoniae AD. 
Dubos and Schaedler (1956) observed an increased re­
sistance to gram positive infections following the adminis­
tration of lipopolysaccharldes. Since gram positive micro­
organisms are not affected by properdin in vitro it was con­
cluded that other defense mechanisms were stimulated by in­
jection of the foreign material. Landy (1956) found that in­
creased resistance following intraperitoneal injection of 
lipopolysaccharide extended only to gram negative bacteria 
while no change in susceptibility was demonstrated to three 
species of gram positive bacteria. The fact that different 
mouse strains were used by these investigators may explain 
the conflicting results, since other variables were similar 
in both studies. 
Hinz and Wedgwood (19 58) studied the mode of action of 
the properdin system on red blood cells, viruses and bac­
teria. Hemolysis, bacteriolysis and virus inhibition, sim­
ilar to the interaction of properdin with zymosan, behave as 
those they are first-order enzyme reactions. Rates of re­
action are independent of substrate concentration and are 
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proportional to the amount of substrate remaining at any time. 
Die addition of properdin increases the rate of reaction. 
The reactions are temperature dependent with an optimum of 
37° C. The optimum pH for PNH (paroxysmal nocturnal hemo­
globinuria) hemolysis and virus inhibition is about 7.0, 
which corresponds to the midpoint of the range over which 
bacteriolysis and interaction with zymosan occur although 
these two reactions have a wider effective pH range. All 
of the reactions require magnesium ions; the optimum concen­
tration for virus inhibition and PNH hemolysis is 0.05 M, 
somewhat greater than for the interaction of properdin with 
zymosan or bacteria. Manganese ions and cobalt ions are the 
only other divalent cations tested which can be substituted 
for magnesium ions in PNH hemolysis, bacteriolysis, and inter­
action with zymosan; only manganese ions can be substituted 
in virus inhibition. All the reactions are almost completely 
inhibited by increases in ionic strength above 0.20. They 
suggest that common or similar polysaccharide structural 
elements with which the properdin system reacts may exist in 
PNH erythrocyte, viruses, and bacteria. 
Blattberg (1956, 1957) has demonstrated that the serum 
of rabbits and guinea pigs which had been injected with 
zymosan incorporated in adjuvants showed an increased bac­
tericidal activity for E. coll. The increased bactericidal 
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activity for E. coli resulting from injections of zymosan 
could be adsorbed by the E. coll• 
Turk (1959) studied the precolostral serum of calves. 
He found that immediately after birth calves have serum 
properdin levels 50 percent plus or minus the values for 
mature animals. Antibody titers to various organisms in pre­
colostral serum were less than 10 percent of the values ob­
tained after the calves had been allowed to nurse. This in­
dicates that properdin is produced actively by the fetus in 
utero or received passively by transplacental transfer. This 
is in direct contrast to the acquiring of antibodies, little 
of which are received prior to ingestion of colostrum, and 
would tend to support researchers who maintain that the pro­
perdin system is separate from the antigen-antibody system. 
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EXPERIMENTAL 
The experiments reported are on permanent file in the 
Swine Nutrition Section of the Animal Husbandry Department, 
Iowa State College, Ames, Iowa, under the identical numbers 
used herein. 
The following procedures and/or materials were common to 
two or more of the experiments reported herein. The pigs used 
in all of these experiments were from crossbred sows (Farmer's 
Hybrid x Poland China x Landrace x Duroc) mated to Farmer's 
Hybrid boars. The pigs were given an iron treatment at 1 day 
of age, castrated at 4 days of age, and vaccinated with a 
mixture of hog cholera and erysipelas serum at 5 days of age. 
All the statistical analyses made by analysis of variance 
procedures were done as outlined by Snedecor (1956). 
The antigen-antibody immunological test employed in one 
of the phases of this study was adapted from the modified 
sheep erythrocyte hemagglutination test described by Westphal 
et al. (1952a, 1952b) and modified by Neter et al. (1956). In 
this procedure the lipopolysaccharide fraction of the micro­
organism cells was extracted and adsorbed on sheep erythro­
cytes, and the modified erythrocytes were then used in the 
hemagglutination tests. This procedure has been outlined in 
Appendix B. 
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Persistence of Colostrum-Acquired Immunity 
The object of this series of experiments was to determine 
the length of time after birth that the baby pig maintains a 
significant amount of colostrum-acquired antibodies to various 
microorganisms. Also, a comparison was made between pigs 
weaned at 2 weeks of age and littermate pigs remaining on 
their dams. 
Experiment 901 
Procedure In Experiment 901 seven adult crossbred 
sows were immunized to Serratia marcescens bacterin in which 
the initial injection was made intravenously 4 to 6 weeks 
prior to parturition. The Initial injection contained approx­
imately 2.4 x 109 cells and each subsequent weekly injection 
was increased by 1.2 x 10® cells until the sows were put into 
the farrowing crates in Unit C (See Appendix A for a descrip­
tion of Unit C). After farrowing the sows and pigs remained 
in Unit C for 2 weeks. 
Serratia marcescens was chosen as the antigen to use 
since it is not normally found in the animal body and does 
not grow at 37° C. Under these conditions little or no con­
tamination would be expected from other strains of Serratia 
marcescens and the results obtained could be considered an 
accurate interpretation of the response obtained from any 
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organism under similar conditions of little or no contamina­
tion. 
Blood samples were drawn from all pigs by anterior vena 
cava puncture at 1 day, 1, 2, -3, 4, 5, and 6 weeks of age and 
antibodies to Serratia marcescens determined by the hemagglu­
tination technique (Appendix B). When each litter reached 
2 weeks of age, half of the pigs were weaned. Where possible, 
two half-litters of the same age remaining on their dams were 
combined and put on one sow so a more valid comparison could 
be made to an intact litter. The weaned pigs were fed 5 
pounds of a prestarter ration (Table 6, Appendix G-) and then 
a starter ration (Table 7, Appendix G-) until the termination 
of the experiment, Littermate pigs on and off sows were 
housed in adjacent pens in Unit G (see Appendix A for descrip­
tion) . Supplemental heat was provided by heat lamps. 
Results and discussion The results of this experiment 
are presented in Figures 1 and 2. The analysis of cover!ance 
of the hemagglutination titers with respect to weeks after 
birth is presented in Table 12 in Appendix H. 
The data in Figure 1 show that the baby pig has a rather 
high level of colostrum-acquired antibodies in his bloodstream 
shortly after birth and that this level decreases rapidly 
during the first 2 weeks of life. Serum antibody titers were 
not determined in the pigs prior to nursing since Speer (1957) 
Figure 1. Serum antibody titer to Serratia marcescens of 
baby pigs receiving antibodies to Serratia 
marcescens from colostrum 
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igure 2. Logarithmic values of antibody titers versus 
age of the pigs 
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has shown that pigs have little or no serum antibodies prior 
to nursing. Speer's (1957) work also showed that the amount 
of colostrum acquired antibodies reached a maximum within 24 
hours. Thus, the author felt that no advantage would be 
gained by determining the serum antibody level prior to 
nursing, and that the maximum level of colostrum-acquired 
antibodies could be observed by a determination at 24 hours 
of age. 
There was significant variation in colostrum-acquired 
antibodies to Serratia marcescens among litters. The average 
serum antibody titer at 1 day of age was 1:930 and the titer 
had dropped to 1:330 at the end of 7 days, and dropped fur­
ther to 1:100 at 14 days of age. 
There was no difference in the serum antibody titer be­
tween the pigs weaned and fed dry feed at 14 days of age and 
littermate pigs allowed to nurse throughout the course of the 
experiment. Consequently, in summarizing the data no differ­
entiation was made between the two groups. The average serum 
antibody titer was 1:35 at 21 days of age, 1:10 at 28 days of 
age, 1:5 at 35 days and 1:2 at 42 days of age. 
In analyzing the data statistically the average serum 
antibody titer for each litter per time interval was trans­
formed to logarithmic values. All zero values were arbi­
trarily assigned a logarithmic value of 1 and the time 
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intervals were accepted as being equal. These assumptions 
and arbitrary values resulted in homogeneous data. A sig­
nificant linear regression (P = 0.01 or less) was found to 
fit these data when analysis of covarianee was made (Table 
12 in the Appendix). The antibody half-life was determined 
using the first order reaction rate equation (In |p = 2t). 
The antibody half-life was found to be 4.9 days, or, in other 
words, a 50 percent reduction occurred in the serum antibody 
titer every 4.9 days. 
Experiments 937A and 957B 
These experiments were designed to study several facets 
concerning active antibody production in baby pigs. The 
primary interest was to study the relationship of active 
antibody response in pigs which had received passive anti­
bodies to the same antigens via the colostrum. The secondary 
interest was to study the antibody response in young pigs with 
and without injections of zymosan. 
Procedure In Experiment 937A nine replications of 
four pigs each were used to study active antibody production 
to E. coll 2A2 and Candida albicans No. 2951. The pigs were 
randomly allotted to the treatments at 1 week of age, although 
they were not weaned from their dams until they were 2 weeks 
old. Treatment (l) served as the control; treatment (2) re­
ceived injections of the E. coll 2A2 and Candida albicans No. 
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2951 mixed bacterin; treatment (3) received Injections of 
zymosan; and treatment (4) was a combination of treatments 
(2) and (3). The bacterin was an equal mixture of E. coll 
A ft 6.0 x 10 cells per ml. and Candida albicans 5.0 x 10 cells 
per ml. The mixed bacterin was rendered non-viable by adding 
0.03 percent formalin. One ml. of the mixed bacterin was 
given intraperitoneally at 7, 10, 14, and 18 days of age. 
Two ml. were given intraperitoneally at 21 and 28 days of 
age. One ml. was given intravenously at 30 days of age and 
2 ml. given intravenously at 32 days of age. Zymosan was 
injected intraperitoneally at the rate of 5.0 mg. per kg. of 
body weight at 14, 21, and 28 days of age. Weekly blood 
samples were drawn from the anterior vena cava and the serum 
was titrated for antibodies to the two immunizing organisms. 
The hemagglutination technique used previously failed to give 
satisfactory results, but a simple agglutination technique 
was found to be satisfactory in determining the serum anti­
body titers. This new procedure is outlined in Appendix C. 
Each pig was fed 5 pounds of the prestarter ration shown 
in Table 6 in the Appendix G and the starter ration shown in 
Table 7 in Appendix G- was fed for the remainder of the experi­
ment. The experiment was conducted in Unit E (see Appendix 
A for description) in individual pens. The experiment was 
terminated when the pigs were 35 days old. Growth and feed 
data measurements were made weekly. 
Seven crossbred and Landraee sows bred to Farmer's Hybrid 
boars were immunized to a mixed bacterin of E. coll 2A2 and 
Candida albicans No. 2951 in Experiment 937B. 'The number and 
size of the immunizing injections, the stage of gestation 
when the injections were given and the average serum antibody 
titer per litter at 24 hours post parturn are presented in 
Table 2. 
When the pigs were 7 days old replications of four pigs 
per replication from the same litter were selected for future 
studies on the basis of weight and serum antibody titers to 
the organisms mentioned above. Pigs in each replication were 
randomly allotted to the following four treatments: (1) con­
trol, (2) injected with the mixed bacterin, (3) injected with 
zymosan and, (4) injected with both the mixed bacterin and 
zymosan. The injections of the mixed bacterin were initiated 
at 7 days of age and the injections of zymosan were initiated 
at 14 days of age. The actual number and size of the injec­
tions are presented in the footnote of Table 3. 
The pigs were weaned at 2 weeks of age and the remainder 
of the experiment was conducted in Unit E. Five pounds of 
the prestarter ration which is shown In Table 6 in Appendix 
G was fed per pig and the starter ration shown in Table 7 in 
Appendix G was fed for the remainder of the experiment. The 
pigs were individually attended, and given feed and water ad 
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libitum. Blood samples were drawn from the anterior vena 
cava at weekly intervals and the serum titrated for anti­
bodies, by the technique shown in Appendix C. Growth and 
feed data measurements were made at weekly intervals. 
Results and discussion The results of Experiment 937A 
are presented in Table 1 and Figure 3. Analysis of variance 
plans and the mean squares for growth, feed efficiency and 
antibody levels at 5 weeks of age are presented in Tables 13 
and 14 in Appendix H. There were no significant differences 
Table 1. Serum agglutination titers to E. coli and Candida 
albicans in pigs at 5 weeks of age 
Average antibody titer 
Treatment E. coll Candida albicans 
Control 
Bacterin8, 
Zymosan™0 
Bacterina + Zymosan* 
Negative 
1:9 
Negative 
1:15 
Negative 
1:1 
1:38 
1:12 
&H • % 10 8 
cells per ml. and Candida albicans 5.0 x 10a cells per ml. 
One ml. of the mixed bacterin was given intraperitoneally at 
7, 10, 14, and 18 days of age. Two ml. were given intra­
peritoneally at 21 and 28 days of age. One ml. was given 
intravenously at 30 days and 2 ml. intravenously at 32 days 
of age, 
^Zymosan was injected intraperitoneally at 5.0 mg. per 
kg. of body weight at 14, 21, and 28 days of age. 
Figure 3. The effect of injections of E. coll and Candida 
albicans mixed bacterin, and zymosan on total 
gain and feed efficiency of baby pigs 
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Table 2. Schedule of immunization of sows to E. coli and 
Candida albicans mixed bacterin and the average 
serum antibody titer of each litter at 24 hours 
of age 
Sow Litter Number of 
number number injections® 
Days 
from last Average litter titer 
injection (24 hours) 
to Candida 
farrowing E. coll albicans 
4919 2410 
11 2460 
2663 2470 
3652 2490 
4263 2560 
4260 2620 
4051 2710 
4 9 
5 7 
5 8 
5 9 
5 15 
5 16 
5 18 
1:785 1:160 
1:183 1:86 
1:451 1:196 
1:51 1:16 
1:102 1:52 
1:124 1:84 
1:90 1:110 
^Injection number 1 was 5.0 ml. of 9.0 x 10® cells per 
ml., number 2 was 10.0 ml. of 9.0 x 10® cells per ml., numbers 
3, 4, and 5 were 10.0 ml. of 1.5 x 10® cells per ml. The 
bacterin was an equal mixture of E. coll and Candida albicans. 
in growth rate or feed efficiency among the four treatments. 
Serum antibody titers to E. coll 2A2 and Candida albicans No• 
2951 obtained at 5 weeks of age in Experiment 937A are pre­
sented in Table 1. Since the antibody titers determined 
prior to 5 weeks of age in Experiment 937A by the hemagglu­
tination technique were of questionable accuracy, these anti­
body titers are not presented. 
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Zymosan apparently has antigenic sites that are common 
to Candida albicans since the pigs injected with zymosan had 
titers to the Candida of 1:33. Also, Candida albicans No. 
2951 appears to be a poor antigen. The pigs receiving injec­
tions of the mixed bacterin produced essentially no anti­
bodies to the Candida. When pigs received injections of both 
bacterin and zymosan only slight antibody responses were ob­
tained. Injections of zymosan had no effect on the produc­
tion of antibodies to E. coll 2A2. The E. coli antibody 
titers were 1:9, 1:0, and 1:15 for the bacterin treated pigs, 
zymosan treated pigs, and the combination treatment of both 
bacterin and zymosan, respectively. 
The results of Experiment 93 are presented in Table 3 
and Figure 4. The analysis of variance plans are presented 
in Tables 13 and 14 in Appendix H. There were no significant 
differences in growth rate or feed efficiency among the four 
treatments. The pigs receiving injections of zymosan gained 
3 percent more than the control pigs, but the feed efficiencies 
of the two groups were the same. The serum antibodies to E. 
coli received passively from the colostrum were not affected 
by injections of bacterin or zymosan after 1 week of age. In 
other words, the injection of these antigens did not cause a 
more rapid decline in serum antibody titer received via the 
colostrum. At 4 weeks of age there was an indication that 
the pigs had commenced to actively produce antibodies to E. 
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Table 3. The effect of injections of E. coli and Candida 
albicans mixed bacterin and zymosan on the serum 
antibody concentration of pigs farrowed by dams 
hyperimmunized with E. coli and Candida albicans 
mixed bacterin 
Age (days) 
Treatment 1 7 14 21 28 35 
Average agglutination titer to E. coli a 
Control 1:264 1:44 1:9 1:7 1:6 1:7 
Mixed bacterin^ 1:256 1:24 1:12 1:3 1:26 1:33 
Zymosan0 1:191 1:26 1:14 1:7 1:6 1:10 
Mixed bacterin^ 
+ zymosan 1:307 1:28 1:14 1:9 1:10 1:20 
Average agglutination titer to Candida albicans8. 
Control 1:94 1:48 1:16 1:13 1:16 1:7 
Mixed bacterin*3 1:87 1:34 1:19 1:12 1:16 1:11 
Zymosan0 1:86 1:24 1:24 1:14 1:11 1:16 
Mixed bac ter in*3 
+ zymosan 1:84 1:29 1:23 1:30 1:16 1:16 
aSee Table 2 for immunization procedure of dams. 
^Bacterin was an equal mixture of E. coli 6.0 x 10® cells 
per ml. and Candida albicans 5.0 x 10® cells per ml. One ml. 
of mixed bacterin was injected intravenously at 7, 14, 17 and 
21 days of age; 2.0 ml. intravensouly at 24 and 28 days of age. 
cZymosan was injected intraperitoneally at 5.0 mg. per 
kg. of body weight at 14 and 21 days of age. 
Figure 4. The effect of injections of E. coli and Candida 
albicans mixed bacterin, and zymosan on total 
gain and feed efficiency of baby pigs passively 
immunized to E. coli and Candida albicans 
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coli. At 5 weeks of age a definite active response to the 
E. coli was evident. There was a statistically significant 
difference (P = 0.01 or less) in the serum antibody titers 
to Candida albicans among the four treatments at 5 weeks of 
age. The zymosan injections increased the antibody titer to 
Candida albicans but had no effect on the antibody titer to 
E. coli. This difference would be expected since Saccharo-
myces cerevisiae. the source of zymosan, is much more closely 
related to Candida species than to Escherichia species. 
These data showed that the baby pig actively produced 
antibodies at 4 to 5 weeks of age. In addition, there 
appeared to be no delay in active antibody production in 
pigs receiving antibodies passively from the colostrum. 
Also, the decay rate of colostrum-acquired antibodies was 
not influenced by injections of the same bacterin used to 
hyperimmunize the dams. 
Active Antibody Production in Baby Pigs 
Experiment 896 
Procedure Twenty-four crossbred pigs averaging 8-5 
lbs. in weight were used in a 2 x -3 factorial design to study 
the effects of a combination of two antibiotics, bacitracin 
and neomycin, on growth, feed efficiency and antibody produc­
tion in pigs injected with physiological saline, Serratia 
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marcescens bacterin and a combination of Serratia marcescens 
bacterin and zymosan. The pigs were weaned at 2 weeks of 
age and allowed 1 week to become adjusted to feed and indi­
vidual pens in Unit E (see Appendix A for description) where 
the experiment was conducted. The antibiotics were incor­
porated in the ration at the level of 10,0 mg. of bacitracin 
and 5.0 mg. of neomycin per pound of total ration. The 
9 bacterin was injected intravenously at the rate of 1.2 x 10 
8 
cells per pig at 3 weeks of age and 3.0 x 10 cells per pig 
at 4 weeks of age. Zymosan was injected intraperitoneally 
at 3 weeks of age at the rate of 5 mg. per kg. of body 
weight. Blood samples were drawn from each pig at 3 weeks 
and 5 weeks of age, and antibody titrations were made on the 
serum by the hemagglutination technique (Appendix B). Growth 
and feed consumption data were collected at the termination 
of the experiment at which time the pigs were 5 weeks old. 
Each pig was fed 5 pounds of prestarter ration (Table 6, 
Appendix G) initially and then starter ration (Table 7, 
Appendix G) for the remainder of the experiment. The pigs 
were allowed free access to running water and the feed through­
out the experiment. 
Results and discussion A summary of the active anti­
body production of the pigs in this experiment is presented 
in Figure 5. The analysis of variance plan and mean squares 
for growth, feed efficiency and antibody titers are presented 
Figure 5. The effect of saline injections, Serratia marcescens 
bacterin injections, and Serratia marcescens bacterin 
plus zymosan injections with and without bacitracin 
and neomycin antibiotic combination on antibody 
response to Serratia marcescens 
CE: 200 
lu 
tl 
H- 160 
160 
O 
fi 120 
< 
80 70 
40 
> 
< e 
BASAL 
B + Z  
4 
S = Saline B = Bacterin 
200 
160 
S B B + Z 
I—ANTIBIOTICS 1 
Zymosan 
49 
in Table 15, Appendix H. The growth and feed data of this 
experiment will be presented under the heading "Effect of 
Zymosan on Growth Rate, Feed Efficiency and Immunological 
Responses." 
The results of this experiment demonstrated that Ser-r 
ratia marcescens could be used as an antigen to study the 
antibody response in baby pigs without obvious interference 
from other organisms ordinarily present in the baby pigs' 
environment. None of the pigs showed any trace of serum 
antibodies to Serratia marcescens at a 1:10 dilution prior to 
the initial injection of the bacterin. When the pigs were 
injected intravenously with 1.2 x 10^ cells (l.O ml. of the 
bacterin) at 3 weeks of age, symptoms of anaphylactic shock 
were observed in every pig. Since previous serum antibody 
titers to Serratia marcescens were negative, this was not 
considered to be due to a sensitivity reaction. This number 
of cells was probably an excess for an initial injection 
for a pig of this age to tolerate intravenously. This may 
also explain the large differences in reduced gain and feed 
efficiency of the treated pigs compared with the control 
pigs injected with physiological saline (Figure 9). 
The treated pigs were given a second intravenous injec­
tion of Serratia marcescens bacterin (3.0 x 108 cells) at 4 
weeks of age and no adverse effects were noted. The summary 
of the antibody titers presented in Figure 5 were made at 5 
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weeks of age. 
It may be noted that both the antibiotics in the ration 
and the zymosan injected intraperitoneal!^ resulted in higher 
serum antibody titers. The addition of bacitracin (10.0 mg. 
per lb. of ration), and neomycin (5.0 mg. per lb. of ration) 
to the ration resulted in an increased in average serum anti­
body titers of better than 50 percent. These two particular 
antibiotics, bacitracin and neomycin, were chosen because they 
would exert their antibacterial effect in the intestinal tract 
and not within the body proper. Thus one would not expect 
the antibody response to be confounded with antibiotics. An 
explanation concerning this difference in serum antibody 
titers due to antibiotics is that there may have been a 
subclinical enteric infection in the pigs not receiving anti­
biotics which resulted in more competition for antigenic 
sites thus reducing the antibody response to Serratia marces­
cens . 
A difference in antibody response of an identical mag­
nitude was observed due to a single intraperitoneal injection 
at 3 weeks of age of 5.0 mg. per kg. of body weight of 
zymosan. The difference in antibody response may be due to 
common antigens possessed by zymosan and Serratia marcescens. 
The serum antibody titrations of the saline control pigs were 
negative at the 1:10 dilution throughout the experiment. 
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Experiment 906 
Procedure The purpose of this experiment was to 
determine the age when baby pigs produce antibodies to anti­
gens injected at the weaning age of 2 weeks. 
Forty-one crossbred pigs weaned at 15 days of age were 
assigned to one pen of five pigs and nine pens of four pigs 
each. Each pig was fed 5 pounds of prestarter ration (Table 
6, Appendix G) and then starter ration (Table 7, Appendix G) 
for the remainder of the trial. Serratia marcescens bacterin 
was injected according to the following schedule: approxi-
ft 
mately 3.0 x 10 cells intraperltoneally at 15 days of age, 
3.0 x 10® cells intravenously at 19 days of age and 6.0 x 10® 
cells intravenously at 22 days of age. Blood samples were 
drawn by anterior vena cava puncture at 15, 19, 24, 30, and 
37 days of age and antibodies to Serratia marcescens deter­
mined by the hemagglutination technique (Appendix B). 
Results and discussion The results of this experiment 
are summarized in Figure 6. These data show that baby pigs 
are capable of producing antibodies actively by 3 weeks of 
age. However, the magnitude of response is quite low and 
could hardly be considered of any significance in protecting 
the baby pig from infections at this age. The average serum 
antibody titer of 92 at 24 days of age is indicative of a 
degree of convalescence before the baby pig is 4 weeks old. 
Figure 6. Antibody response of group-fed pigs immunized 
with Serratia marcescens bacterin 
Av. HEMAGGLUTINATION TITER 
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After the pigs reached the stage of recovery from the 
injected antigen the serum antibody titers diminished quite 
rapidly with an apparent half-life of about 5 days. This 
would indicate that the baby pig soon loses the ability to 
produce antibodies at this early age and that the antibodies 
present in the blood behave as though they had been acquired 
passively. 
Experiment 924 
Procedure Experiment 924 was designed to study the 
antibody response in baby pigs early weaned at 2 weeks of age 
versus littermate pigs remaining on their dams. Four cross­
bred litters, a total of 35 pigs, were used in this experi­
ment . When two litters of pigs of the same age reached 2 
weeks of age, each litter was divided equally by paired 
weights. One-half of the pigs in each of the two litters 
were weaned and the remaining pigs of the two litters were 
combined on one of the sows. The weaned pigs were fed 5 
pounds of près tarter ration (Table 6, Appendix Gj per pig 
and then starter ration (Table 7, Appendix G-) for the remain­
der of the experiment. The pigs on both treatments were 
housed in the same building (Unit G-8; see Appendix A for 
description) in adjacent pens. Serratia marcescens bacterin 
was Injected intravenously in all pigs at 14 and 21 days of 
8 
age at the rate of 5.0 x 10 cells per injection. Blood 
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samples were drawn from each pig by anterior vena cava punc­
ture at 2, 3, 4, and 5 weeks of age and serum antibody titers 
determined by the hemagglutination technique (Appendix B). 
The experiment was terminated when the pigs were 5 weeks old. 
Results and discussion The results of this experiment 
are summarized in Figure 7. These results indicate that the 
ability of the baby pig to produce antibodies actively is not 
influenced by early weaning at 2 weeks of age. The magnitude 
of the antibody response was the same whether the pigs were 
weaned at 2 weeks of age or left with the sow. The injection 
g 
schedule (3.0 x 10 cells intravenously at 14 and 21 days of 
age) was tolerated very well by all of the pigs and no adverse 
effects were observed in any of the pigs. 
Effect of Zymosan on Growth Rate, Feed Efficiency 
and Immunological Responses 
Zymosan is the insoluble residue of baker's yeast follow­
ing exhaustive autolysis, trypsin digestion and alcohol pre­
cipitation. It is a complex polysaccharide made up of about 
95 percent glucose units (Ross (1958b)). Ross ( 1958a) states 
that zymosan has several features favorable for animal studies 
in that injection of zymosan elevated properdin levels for 
longer periods than most other polysaccharide complexes. 
Furthermore it is well tolerated by most experimental animals. 
The preparation of the zymosan suspension for injection 
Figure 7. Antibody response of baby pigs weaned at 2 weeks 
of age versus littermate baby pigs allowed to 
nurse their dams past 2 weeks of age 
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was carried out according to the following procedure. Boil 
gently 2.0 gm. of zymosan in 100 ml. of distilled water for 
45 minutes adding distilled water periodically to maintain 
the volume. Decant the supernatant and resuspend the pre­
cipitate in sterile isotonic saline at a concentration of 20 
mg. of zymosan per ml. of suspension. Add 0.03 percent form­
alin to prevent bacterial contamination. Use aseptic tech­
niques throughout the preparation. 
The objective of this series of experiments with zymosan 
was to determine if young pigs will respond to injections 
of zymosan with an increase in growth rate and feed efficiency. 
Experiment 866 
Procedure Seventy-eight crossbred pigs were used in 
three trials in Experiment 866 to study the effect of intra­
peritoneal injections of zymosan on weight gains of baby 
pigs. These pigs were those least desirable for experimental 
purposes which remained on their dams after the more uniform 
pigs had been selected for other experiments. Ordinarily the 
culled pigs from each farrowing are removed from their dams 
between 2 and 3 weeks of age and moved into a building with 
a single pen where they are housed until they are vaccinated 
for hog cholera and erysipelas at approximately 35 pounds. 
At the initiation of each trial all of the pigs of approxi­
mately the same age were weighed and allotted randomly to two 
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treatments. 
The zymosan suspension was injected intraperitoneal^ 
at the rate of 10.0 mg. per kg. of body weight. Each control 
pig was injected intraperitoneally with 2.0 ml. of sterile 
isotonic saline. In Trial 1 and Trial 3 only a single injec­
tion was given and it was at the initiation of the trial; 
however, in Trial 2 a second injection was given after the 
trial had been in progress for 1 week. Growth measurements 
were made weekly but no feed data were collected. 
All pigs in each trial were fed Ration A (Table 8, 
Appendix G), and were housed in Unit G (see Appendix A for 
description) in a common pen. Supplemental heat was furnished 
by gas heaters as needed. Each trial was terminated after 3 
weeks. 
Results and discussion The results of Experiment 866 
are summarized in Table 4. The analysis of variance plan for 
each trial in this experiment may be seen in Table 16 in 
Appendix H. 
All of the pigs in Trial 1 were weaned between 2 and 3 
weeks of age and were placed immediately on dry feed. When 
the pigs were 5 weeks of age they were weighed individually 
and then given the intraperitoneal injection of either zymosan 
or physiological saline. This random assignment to treatments 
resulted in the 2 pounds differential in initial weight. 
The pigs injected with zymosan gained an average of 0.64 
Table 4. Effect of intraperitoneal injections of zymosan on baby pig growth 
Treatment 
Number 
pigs 
Age at 
zymosan 
injection 
(days) 
Initial 
weight 
(lbs.) 
Final 
age 
(days) 
Final 
weight 
(lbs.) 
Gain for 
period 
( lbs. ) 
Increase 
over 
control 
(lbs.) 
Trial 1 
Zymosan 
(10 mg./kg.) 
Saline 
18 
21 
35 
35 
14 .0 
16.0 
Trial 2 
56 
56 
30.28 
31.64 
16.28 
15.64 
+0.64 
Zymosan 
(10 mg./kg.) 
Saline 
10 
8 
17 & 24 
17 & 24 
9.94 
9.94 
Trial 3 
38 
38 
16.55 
17.62 
6.67 
7.68 
-1.01B 
Zymosan 
(10 mg./kg. ) 
Saline 
11 
10 
24 
24 
8.62 
9.40 
45 
45 
13.69 
11.64 
5.07 
3.03 
+2.04 
^Difference significant at P = 0.01 or less. 
61 
pounds more than the control pigs over the 3 weeks experi­
mental period; a difference of 4.0 percent. This was not 
statistically significant at P = 0.05 or less. 
In Trial 2 the treated pigs received two injections of 
10 mg. per kg. of body weight of zymosan and they were 18 
days younger than the pigs on Trial !• The pigs treated 
with zymosan in Trial 2 gained 1.01 pounds less than the con­
trol pigs over the experimental period of 3 weeks. This was 
a 13.0 percent difference in total gain and it was statis­
tically significant at P = 0.05 or less. It was unfortunate 
that Trial 2 was not carried at least another week for it was 
shown in later experiments that the Immediate effect of zymosan 
injections was a slight reduction in gain, however, this was 
overcome in other experiments. 
The pigs in Trial 3 receiving a single zymosan injection 
of 10 mg. per kg. of body weight at 24 days of age gained 
67.0 percent more than the control pigs over the experimental 
period of 3 weeks. It must be pointed out, however, that 
these pigs weighed less than 15,0 pounds at 45 days of age and 
thus could hardly be considered as average pigs. 
The combined results of these three trials do indicate 
that a slight advantage in gain may be expected by giving 
pigs, of comparable age, an intraperitoneal injection of 
zymosan. 
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Experiment 880 
Procedure Forty crossbred pigs were randomly allotted 
to ten replications of four treatments by littermate outcome 
groups to study the effect of age on zymosan injection. All 
of the pigs were weaned at 2 weeks of age and allotted to 
their treatments at 3 weeks of age. The experimental period 
was 5 weeks. The treatments were as follows: (1) 2 ml. 
saline as the control; (2) 10 mg./kg. of body weight of 
zymosan injected at 3 weeks and again at 4 weeks of age, 
(3) 10 mg./kg. of body weight of zymosan injected at 4 weeks 
and again at 5 weeks of age, (4) 10 mg./kg. of body weight 
of zymosan injected at 5 weeks and again at 6 weeks of age. 
All pigs were weighed each week, but feed data could not be 
collected since each pen contained an entire replication. 
After weaning, each pig was fed 10 pounds of prestarter (Table 
6, Appendix G) and then the starter ration (Table 7, Appendix 
G) for the remainder of the experiment. The experiment was 
conducted in Unit A (see Appendix A for description) and the 
pigs were allowed free access to feed and water at all times. 
Results and discussion The results of this experiment 
are presented graphically in Figure 8. The analysis of vari­
ance plan and the mean squares for total gains are presented 
in Table 17 in Appendix H. 
This experiment demonstrates that intraperitoneal injec-
Figure 8. The effect of two injections of 10.0 mg. of 
zymosan per kg. of body weight versus age of 
injection on growth of baby pigs 
PERCENT DEVIATION FROM CONTROL GROUP 
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tions of zymosan result in a slight stimulation of gain. In 
the case of the group of pigs receiving injections of zymosan 
at 3 and 4 weeks of age, the rate of gain compared to the con­
trol group decreased until the pigs reached 5 weeks of age 
at which time the deficit in gain was nearly 10 percent less 
than the gain of the control group. At 6 weeks of age the 
gains of the group injected at 3 and 4 weeks of age was 15 
percent greater than that of the control group. At 7 and 8 
weeks of age the gains had leveled off 5 percent greater than 
that of the control group. 
In the case of the group of pigs receiving zymosan injec­
tions at 4 and 5 weeks of age, the low point in gains compared 
to the control group occurred at 5 weeks of age, and was 5 
percent less than the gain of the control group. The peak of 
the growth curve was reached at 7 weeks of age, and was 4 per­
cent greater than that of the control. At 8 weeks of age 
there was no difference in the total gains of the pigs inject­
ed with zymosan at 4 and 5 weeks of age and the pigs in the 
control group. 
In the case of the pigs injected at 5 and 6 weeks of 
age, the characteristic decrease in gain was not observed the 
first week after the initial injection. However, the decrease 
in gain was evident at 7 weeks of age where it was 9 percent 
less than that of the control group. One week later, at 8 
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weeks of age, the pigs receiving zymosan injections had made 
gains 16 percent greater than the control group. 
It was observed in this experiment and in Experiment 866, 
discussed previously, that immediately after the injections 
of zymosan the pigs fail to gain as well as untreated pigs, 
yet this handicap is overcome 2 to 3 weeks after the last in­
jection of zymosan. This indicates that zymosan is acting as 
an antigen. Ross (1958b) has observed similar increases in 
gain in other species attributable to injections of zymosan. 
Ross (1958b) offers the theory that zymosan stimulates the 
properdin system and subsequently increases the resistance of 
animals to various infections. The author sees no reason to 
differ with Ross (1958b), although he feels that there is a 
possibility that zymosan possesses antigens common to various 
microorganisms that may be slightly pathogenic to young pigs. 
Thus, the young pig with a greater ability to ward off sub­
clinical infections responds with an increased growth rate. 
Experiment 896 
Results and discussion The procedure and a portion 
of the results of this experiment has been presented in a pre­
vious section. The results of the portion of this experiment 
to be presented in this section are shown in Figure 9. In 
this experiment, individual gain and feed consumption data 
Figure 9. The effect of saline injections, Serratia marcescens 
bacterin injections and Serratia marcescens bacterin 
plus zymosan injections, with and without bacitracin 
and neomycin antibiotic combination on total gain 
and feed efficiency of individually-fed pigs 
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were collected in addition to the serum antibody data present­
ed previously. The pigs receiving the antibiotics bacitracin, 
10.0 mg. per lb. of feed, and neomycin, 5.0 mg. per lb. of 
feed, gained 0.13 lbs. more on 0.10 lbs. less feed per lb. of 
gain than did those pigs receiving no antibiotics. 
As mentioned earlier the pigs receiving intravenous in­
jections of Serratia marcescens bacterin were set back with 
symptoms of anaphylactic shock so a comparison of the growth 
and feed data to the saline control pigs is not justified. It 
is obvious in Figure 9 that the saline control pigs outper­
formed all of the others. Even though the set-back due to 
shock may not have accounted for all of the difference in 
favor of the control pigs, it undoubtedly is responsible for 
some of the difference. 
The difference in total gain of the group injected with 
bacterin plus one injection of 5.0 mg. per kg. of zymosan is 
0.3 lbs. or about 3 percent greater than the total gain of the 
group injected with only bacterin. The feed data collected 
in this experiment showed that feed required per pound of gain 
was nearly 6 percent less for the pigs injected with bacterin 
plus zymosan compared to the pigs injected with bacterin only. 
Also, the observation was made that the effects of the anti­
biotics, neomycin and bacitracin, appeared to be additive 
with the effects of zymosan injections for both total gain and 
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feed efficiency. 
Experiment 912 
Procedure Forty crossbred pigs were randomly allotted 
to four replications of two treatments to study the effect of 
intraperitoneal injections of zymosan on both growth and feed 
efficiency. The experiment was conducted in Unit B (see 
Appendix A for description). At the initiation of the experi­
ment the pigs were 31 days old and they weighed an average 
of 16 pounds. The experiment was terminated after 21 days. 
The zymosan was injected at the rate of 5.0 mg. per kg. of 
body weight initially and again after 1 week on the experi­
ment. Ten pounds of starter ration (Table 7, Appendix G) was 
fed each pig and then they were fed Ration B (Table 8, Appen­
dix G) for the remainder of the experiment. Running water 
and the feed were offered ad libitum throughout the experi­
ment . 
Results and discussion A summary of this experiment 
is presented in Figure 10. The analysis of variance plan is 
presented in Table 18 in Appendix H. The average dally gains 
for the pigs receiving two intraperitoneal injections of 5.0 
mg. per kg. of body weight of zymosan was 4 percent greater 
than the average daily gains of the control pigs. This dif­
ference was not statistically significant. The injections of 
zymosan resulted in a 6 percent improvement in feed effi-
Figure 10. The effect of two injections of 5.0 mg. of 
zymosan per kg. of body weight on growth and 
feed efficiency of baby pigs 
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ciency; a difference statistically significant at P = 0.01 
or less. In the case of the average daily gains, perfect 
littermate control was not possible and this resulted in a 
larger error term. 
The 4 percent improvement in gain was of about the same 
magnitude as observed in previous experiments. These differ­
ences in Improvement of gain and feed efficiency are indica­
tive of a healthier animal. 
Experiment 945 
Procedure Twenty-four crossbred pigs were randomly 
allotted to two replications of four treatments to study the 
effects of different levels of intraperitoneal injections of 
zymosan on growth and feed efficiency. The pigs were weaned 
at 2 weeks of age and given 5 pounds of prestarter ration 
(Table 6, Appendix C-) and then starter ration (Table 7, 
Appendix G-) until they were 4 weeks of age. This constituted 
the pre-experimental treatment. At 4 weeks of age the pigs 
were reallotted by the previous 2 week gain to the experi­
mental treatments. Fifteen pounds of starter ration (Table 
7, Appendix G-) was fed to each pig and then they were fed 
Ration B (Table 8, Appendix G) until the experiment was 
terminated. The four treatments were 2 ml. of sterile iso­
tonic saline injections as the control and 2.5, 5.0 and 10.0 
mg. per kg. of zymosan injected intraperitoneally. All of 
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the pigs were treated at the initiation of the experiment and 
again 1 week later. The experiment was conducted in Unit A 
(see Appendix A for description) and terminated after 4 weeks. 
Feed and water were given ad libitum. 
Results and discussion The results of this experiment 
are presented in Figure 11. The analysis of variance plan is 
presented in Table 19 in Appendix H. These results indicate 
that the optimum level of intraperitoneal injections of 
zymosan for young pigs is between 2.5 and 5.0 mg. per kg. of 
body weight. The levels of 2.5 and 5.0 mg. per kg. of body 
weight resulted in virtually the same average daily gain as 
that of the control group, but their feed efficiency was im­
proved by 5 percent. The level of 10 mg. per kg. of body 
weight of zymosan was apparently too high. It reduced the 
average daily gain by 7 percent and the feed efficiency was 
the same as that of the control group. 
No statistically significant difference at P = 0.10 or 
less was observed in this experiment with respect to gain or 
feed efficiency. However, the same differences observed in 
the previous experiments with respect to improved gain and 
feed efficiency are apparent in this experiment. 
Experiment 964 
Procedure Thirty-two crossbred pigs weighing an aver­
age of 14.0 pounds were allotted to two replications of two 
Figure 11. The effect of two injections of 2.5, 5.0 or 10.0 
mg. of zymosan per kg. of body weight on growth 
and feed efficiency of baby pigs 
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treatments to study the effect of 5.0 mg. per kg. of body 
weight of zymosan injected intraperitoneal^ at the beginning 
of the experiment and again 1 week later. All of the pigs 
were weaned at 2. weeks of age and given a starter ration sim­
ilar to the one in. Table 7 of Appendix G-. The pigs were 31 
days of age when allotted to this experiment. The experiment 
was conducted in Unit G-9, described in Appendix A, and the 
temperature was maintained between 60° F. and 70° F. through­
out the experiment. Ration A (Table 8, Appendix G) was fed 
throughout the experiment. Feed and water.were given ad 
libitum. The experiment was terminated after 3 weeks. 
Results and discussion The results of Experiment 964 
are presented in Figure 12. The method of statistical anal­
ysis is presented in Table 20 in Appendix H. The pigs receiv­
ing two Injections of 5.0 mg. per kg. of zymosan gained an 
average of 10.08 lbs. with a feed conversion ratio of 2.11 
lbs. of feed per pound of gain over the 3 week period whereas 
the control pigs gained 6.31 lbs. with a feed conversion ratio 
of 2.29 lbs. of feed per pound of gain. This is a 59.7 per­
cent improvement in gain and 9.0 percent improvement in feed 
efficiency. These improvements due to the Injection of 
zymosan were not statistically significant at the 0.05 per­
cent level. One more replication would have been necessary 
to have produced significance at P = 0.05 or less. 
In this experiment six pigs failed to gain during the 
Figure 12.  The effect of two injections of 5.0 mg. of 
zymosan per kg. of body weight on growth snd 
feed efficiency of baby pigs 
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3-week experimental period. Consequently, the observations 
for these pigs were removed from consideration. An estimate 
of the amount of feed consumed by these pigs was prepared by 
the following formula derived by Hays (1359): 
daily feed intake (lbs.) = (initial weight x 0.03913 lbs.) 
+ (average daily gain x 0.8273 lbs.) + 0.1927. 
Experiment 9370 
Procedure Eight pigs weaned at 2 weeks of age were 
used in this experiment to study the effect of zymosan injec­
tions on resistance to infection. The pigs were housed in a 
common pen on concrete. Supplemental heat was provided by a 
heat lamp. The prestarter ration (Table 6, Appendix G-) and 
water were given ad libitum. The pigs were allowed 3 days to 
become adjusted to dry feed. Body temperatures were deter­
mined 72, 48, 24, and 0 hours prior to challenge. After It 
was determined that none of the pigs had an abnormal tempera­
ture, two pigs were selected at random to receive 5.0 mg. of 
zymosan per kg. of body weight and two pigs were selected at 
random to receive 10.0 mg. of zymosan per kg. of body weight. 
The remaining four pigs served as controls. The injections of 
zymosan were made intraperitoneally at 24 hours prior to 
challenge. The pigs ranged from 10 to 12 lbs. in weight at 
the time of challenge. 
Three ml. of a 24 hour brain heart infusion broth cul­
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ture of E. coll RB4, 9.95 x 10 cells per ml., were Injected 
Intraperltoneally into each pig at 3 weeks of age. The 
organism had been passed through two mice since storage under 
refrigeration to enhance its virulence. 
Results and discussion The results of this experiment 
are presented in Table 5. These data indicate that the proper­
din system of a 3 week old pig may be stimulated by injections 
of zymosan. These data also indicate that an injection of 
zymosan will increase the resistance of baby pigs to infec­
tion. Although these data are limited in numbers, they do 
demonstrate the protection afforded by zymosan. The amount 
of zymosan necessary for protection, when challenged 24 hours 
later, is approximately 5.0 mg. per kg. of body weight. It 
would have been difficult to have established a minimum lethal 
dose for this particular organism. Hsd s minimum lethal dose 
been given, the possibility exists that the pigs receiving 10 
mg. of zymosan per kg. of body weight might also have been 
protected. Although this experiment does not mean that 
zymosan injections will protect pigs from pathogenic organ­
isms, it does demonstrate that secondary invaders such as E. 
coli may be controlled and consequently the resistance to 
disease increased. 
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Table 5. The effect of two levels of zymosan injections on 
the ability of 3 week old pigs to resist infection 
with E. coll R334 
Treatment8" 
Pig 
Body 
(hours 
temperature of pigs 
prior to challenge) 
Time of death 
(hours after 
number 72 48 24 0 challenge) 
Control 2773S 103.7 102.5 102-6 102.8 6.5 
Control 27655 103.2 103.2 103.1 102.5 4-6 
Control 2761B 103.0 103.2 103.2 102.9 4-6 
Control 2765B 103.8 101.8 103.0 103.6 7 
Zymosan 
5 mg./kg. 2764S 102.8 103.2 102.6 102.1 Survived 
24 hours 
pre-challenge 2756B 102.6 102.9 102.6 102.6 Survived 
Zymo san 
10 mg./kg. 2740S 102-1 103.2 102.0 101.0 12 
24 hours 
pre-challenge 2741B 101.6 102.8 103.1 102.9 6 
aAll pigs were challenged intraperitoneally with 3.0 ml. 
of a 24 hr. broth culture of E. coli RB4, the cellular concen­
tration of which was 9.95 x 108 cells per ml. 
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GENERAL DISCUSSION 
Colostrum-acquired antibodies persist in the baby pig for 
at least 6 weeks after birth although the level of serum anti­
bodies is quite low from 3 weeks of age until 6 weeks of age. 
This is in agreement with the work of Young and Underdahl 
(1949, 1950). In both of the experiments concerning colostrum-
acquired antibodies, serum antibody levels were high enough 
to be classed as protective levels for the first 2 weeks of 
life. At 3 weeks of age the serum antibody levels are such 
that it would be questionable as to whether or not they would 
offer complete protection "from infection. 
The 4-week-old pig is able to actively produce antibodies 
in sufficient quantities that would seemingly offer protection 
from infection. The pig is definitely capable of actively 
producing antibodies by 18 days of age as may be seen in 
Experiment 906, yet this low level of serum antibodies at 18 
days of age would only be indicative of an infection whereas 
the antibody titer of 1:92 at 24 days of age is indicative of 
a certain amount of convalescence. 
The period between 2 and 4 weeks of age seems to be the 
most difficult time for maintaining fairly high serum anti­
body titers. The passively acquired antibodies have diminish­
ed to a rather low level and the active antibody producing 
mechanism is not very strong until after 4 weeks of age. When 
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the pig has received colostrum-acquired antibodies to the 
organism used for active immunization, the active antibody 
response seems to be a few days later than when inherited 
antibodies are not present. The evidence here supports the 
findings of Cooke (1948), Butler et al. (1950), and Barr and 
Glenny (1954) who found that infants with inherited diphtheria 
antitoxin responded less readily to active Immunization. 
Injections of zymosan have no adverse effect on the 
length of life of colostrum-acquired antibodies. In Experi­
ment 896 zymosan injections actually stimulated active anti­
body production. Zymosan injections result in increased re­
sistance to infection at 3 weeks of age, and this may bridge 
the low period in serum antibody concentration from 2 to 4 
weeks of age. 
Active antibody production was demonstrated from 18 days 
of age on up to 5 weeks of age. By 24 days of age the active 
antibody titer is such that considerable protection from in­
fection is possible. There is no difference in active anti­
body production between early weaned pigs compared to sow 
raised pigs. 
No adjuvant was used in any of the bacterins used in this 
study. As suitable adjuvants are found repeated injections 
will be unnecessary in this type of study. By utilizing a 
proper adjuvant one Intraperitoneal injection would be suffi­
cient to maintain a high level of antigen for antibody produc­
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tion for several weeks. By using bacterins in a depot form 
(adjuvant added to the bacterin), hyperimmunization of sows 
may be accomplished with a minimum of time and effort. 
The half-life of the colostrum-acquired antibodies to 
Serratia marcescens is 4.875 days. In Experiment 901 the 
antibody titer was 1:930 at 1 day of age. There was some 
variation from the calculated antibody half-life in serum anti­
body titers actually observed. Since the antibody half-life 
formula was derived from the actual serum antibody values* 
variation from the formula is expected. However, the real 
value of the half-life formula is in anticipating the serum 
antibody concentration at 1 day of age. Other organisms may 
not have antibody decay rates the same as Serratia marcescens. 
Investigations would be necessary with each specific organism 
in order to predict the antibody titer at a certain age. 
The mode of action of the zymosan stimulation of growth 
and improvement in feed efficiency in young pigs is probably 
through the stimulation of the disease resistance mechanism. 
It has been proven that injections of zymosan stimulates the 
serum properdin level, and that the serum properdin level is 
directly related to the disease resistance of mice (Pillemer 
and Ross (1955); Ross (1958a); Kiser et. al. (1956)). Although 
no research has besn reported concerning the serum properdin 
level in swine as related to disease, it is logical to assume 
that the same resistance pattern would hold true for swine as 
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was the case in mice. Kent et al. (1957), by improved methods 
of analysis, have shown that swine serum contains from 50 to 
100 percent more properdin than human serum. Since adult 
swine seem to be quite resistant to many infections, not in­
cluding highly virulent diseases such as hog cholera, one 
could now explain this resistance partially by the theory of 
the properdin system. There is no report in the literature 
concerning the serum properdin level in swine from birth to 
maturity. Turk (1959) has shown that calves immediately after 
birth have a serum properdin concentration that is nearly as 
high as the serum properdin concentration in mature cows. 
Turk (1959) failed to mention any serum properdin levels be­
tween 1 day of age and maturity» He suggested that the calves 
obtained the high serum properdin level passively in utero 
and should this be the case, one would expect a normal dis­
appearance of the passively acquired properdin with age. 
Active serum properdin production would be expected to be 
initiated as the calf increases in age, perhaps about the 
same time that active antibody production occurs. 
The stimulation in growth and feed efficiency caused by 
injections of zymosan indicates that the serum properdin level 
has been stimulated. In all of the experiments reported 
herein, the maximum response in stimulation of growth and 
feed efficiency resulting from zymosan injections occurred 
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at approximately 5 weeks of age. This indicates that the 
properdin system in the baby pig is not as strong at 2 to 3 
weeks of age as it is at 5 weeks of age. Under these condi­
tions and assumptions, active properdin production parallels 
the active antibody production in baby pigs. However, the 
properdin system seems to be functional at 3 weeks of age. 
When pigs 3 weeks of age were challenged with E. co11 
RB4 after having been injected with 5.0 mg. of zymosan per 
kg. of body weight protection from death loss was possible 
with zymosan. Pillemer and Ross (1955), Ross ( 1958a) and 
Kiser et al. (1956) made similar observations with adult 
mice. Even though the properdin system of young pigs may not 
be functioning up to the level of adult animals, it neverthe­
less is adequate to overcome an overwhelming infection due 
to E. coll. 
Three hundred and ten pigs have been used in eight 
experiments studying the effects of Injections of zymosan. 
The over-all average improvement in growth and feed effi­
ciency was 11=25 percent and 4.88 percent, respectively. 
Three of these experiments involving 96 pigs were conducted 
in Unit E under relatively disease free conditions. There was 
no improvement in growth or feed efficiency under these con­
ditions. The improvement in growth was 0.91 percent and the 
improvement in feed efficiency was 0.82 percent. Another 
fact that must also be considered in this lack of response in 
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growth and feed efficiency is that the pigs used in experi­
ments in Unit E were injected at 3 weeks of age or younger. 
In contrast, 214 pigs were used in five experiments in build­
ings other than Unit E where the disease level is accepted as 
being considerably higher than in Unit E, These pigs had an 
average improvement in growth and feed efficiency of 16 per­
cent and 6.75 percent, respectively. The pigs housed in 
buildings other than in Unit E ranged in age, at the time of 
injection of zymosan, from 17 days to 6 weeks with the major­
ity of them receiving injections at approximately 5 weeks of 
age. The group of pigs that were inhibited in growth due to 
zymosan were in Trial 2 of Experiment 866. These pigs were 
housed in a building that would be classed as a high disease 
area and they were less than 3 weeks of age when allotted and 
injected with zymosan. 
The probability exists that substances other than zymosan 
will result in "better doing" pigs when given parenterally. 
In the investigations with iron-dextran compounds as anti-
anemia treatments, Zimmerman et al. (ça. 1959) and Rydberg et 
al. (1959) have observed growth responses over more conven­
tional anti-anemia treatments such as pastes, pills or soil 
treatments. In addition, Ullrey et al. (1959) observed higher 
gamma globulin levels in pigs injected with iron-dextran. 
Kiser et, al. (1956) have demonstrated conclusively that mice 
are more resistant to infections after injections of dextran, 
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in addition to other polysaccharide type compounds. Sheffy 
(1958) has shown that pigs have a greater resistance to 
transmissible gastro-enteritis and hog cholera when the anti-
anemia treatment was an iron-dextran compound. The author 
does not intend to minimize the absolute necessity of iron in 
• anti-anemia treatments, but he does feel that an important 
part of the iron-dextran anti-anemia compound, the dextran, 
has been overlooked in the past. Although dextran has been 
shown to stimulate the properdin system, the stimulation due 
to dextran is somewhat less than the stimulation of the 
properdin system due to zymosan (Ross (1958a)). 
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SUMMARY 
Two experiments were conducted to study the colostrum-
acquired antibodies in baby pigs. Using Serratia marcescens 
bacterin to hyperimmunize sows, it was determined that anti­
bodies to Serratia marcescens were maintained in the serum of 
offspring for at least 6 weeks after birth. The average anti­
body titers determined by hemagglutination were 1:930, 1:330, 
1:100, 1:35, 1:10, 1:5 and 1:2 for- 1 day, 1, 2, 3, 4, 5, and 
6 weeks of age, respectively. The antibody half-life was 
calculated to be 4.875 days. There was no difference in 
serum antibody titers between pigs weaned at 2 weeks of age 
and those allowed to remain on the sow. In another experi­
ment sows were immunized with a mixed bacterin of Escherichia 
coll and Candida albicans. The pigs were injected with the 
mixed bacterin beginning at 1 week of age and/or zymosan at 
2 and 3 weeks of age. No differences in antibody titers were 
observed until the pigs were 4 weeks old at which time the 
groups actively immunized showed higher antibody titers. No 
differences were observed due to the injection of zymosan. 
Four experiments were conducted to study active antibody 
production in baby pigs. Individually attended pigs injected 
with Serratia marcescens at 3 and 4 weeks of age produced 
antibodies up to a 1:200 dilution at 5 weeks of age. The 
addition of bacitracin, 10 mg./lb. ration, and neomycin, 
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5 mg./lb. ration, or zymosan, 5 mg./kg. of body weight, in­
jected intraperitoneally at 3 weeks of age resulted in a 56 
percent increase in antibody titers. Baby pigs weaned and in­
jected with Serratia marcescens bacterin at 2 weeks of age 
produce antibodies by 18 days of age although at very low 
levels. Significant antibody levels are obtained by 4 to 5 
weeks of age when baby pigs are weaned and injected at 2 weeks 
of age. No difference in antibody response was obtained when 
baby pigs weaned and "on sows" were injected with bacterin at 
2 and 3 weeks of age. 
Two hundred and fourteen pigs were used in five experi­
ments to observe growth and feed efficiency of pigs injected 
with zymosan under average sanitation conditions. Growth was 
improved by 16 percent and feed efficiency improved by 6.75 
percent due to intraperitoneal injections of zymosan. From 
three levels that have been tested, 2.5, 5.0, 10.0 mg. per kg. 
of body weight, 5.0 mg. of zymosan per kg. of body weight 
appears to be the optimum level for improving growth and feed 
efficiency. Pigs under 3 weeks of age in a very low disease 
environment are not influenced grossly by injections of 
zymosan. 
In another experiment, two pigs injected with 5.0 mg. 
per kg. of body weight, two pigs injected with 10 mg. per kg. 
of body weight of zymosan 24 hours prior to challenge, and 
four control pigs were all challenged at 3 weeks of age with 
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3 ml. of a 24 hour culture of Escherichia coll. All control 
pigs were dead within 8 hours and both pigs injected with 
10.0 mg. of zymosan per kg. of body weight were dead within 
12 hours. Both pigs injected with 5.0 mg. of zymosan per 
kg. of body weight survived. 
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APPENDIX A 
Description of Experimental Buildings 
Units A and B - these buildings are identical. They have 
doubled-tile walls, concrete floors, and ten group-pens each 
with adequate space for five pigs until 8 weeks of age. They 
are heated by small gas heaters and heat lamps are provided 
if supplemental heat is needed for young pigs. Self-feeders 
and continuous flow waterers are provided. The pens are 
cleaned daily and wood shavings are used for bedding. 
Unit C - this centrally heated building contains 24 indi­
vidual farrowing pens where all of the pigs used in these 
experiments were farrowed. The sows are hand-fed individually 
and water is available at all times from automatic waterers. 
Light bulbs (100 watts) are used in each pen as an attracting 
light to reduce overlaying. The pens are cleaned daily and 
wood shavings are used for bedding. The sows have no oppor­
tunity to leave the farrowing pens until the pigs are weaned. 
Unit E - this building contains 36 individual pens. The 
pens are arranged on a concrete slab which is radiantly heated 
by circulating hot water from a thermostatically controlled 
hot water heater. The building temperature is regulated with 
an air-conditioning, forced-air gas furnace combination unit. 
Germicidal lamps surrounding the walls of this building are 
on continuously• The air is positively exhausted continuously 
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and all air entering the building passes through a bank of 
germicidal lamps. Continuous-flow waterers and self-feeders 
are used in this building. These pens are cleaned daily and 
no bedding is provided. 
Units G - these are nine non-insulated buildings with an 
outer shell of either aluminum, steel, or wood, containing 
four group-pens each with adequate space for ten pigs until 
8 weeks of age. These buildings are not heated but heat lamps 
are provided for young pigs needing supplemental heat. Self-
feeders and automatic waterers are provided for each pen. 
The floors are concrete and they are cleaned daily and wood 
shavings are used for bedding. 
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APPENDIX B 
Procedure for Hemagglutination Technique 
In the extraction of the lipopolysaccharide fraction by 
the method of Westphal et al. (1952a, 1952b), 10 liters of 
nutrient broth were sterilized and inoculated with the E. 
coll strain isolated from a rabbit. After 24 hours growth 
with aeration at 37° C., the medium was centrifuged in a 
Sharpies centrifuge and the organisms were collected. Ten 
grams of acetone dried bacteria were then suspended in 160 
ml. of distilled water and cooled to 2° C., and 265 ml. of 
75 percent phenol were added slowly with agitation. After 
standing 30 minutes in the cold with occasional shaking, the 
mixture was centrifuged in the cold (1500 r.p.m. for 30 min­
utes), the supernatant decanted, and the cells discarded. 
The phenol-water extract containing the lipopolysaccharide 
antigenic substances wss then di'alyzed for 2 days against 
tap water and then for 1 day against distilled water. The 
material was filtered, 6 volumes of ethyl alcohol added, 10 
ml. of ethyl alcohol saturated with sodium acetate added, 
and filtered. The precipitate was dried in a vacuum oven, 
and after being ground, it was used in the preparation of the 
modified sheep erythrocytes. 
Sheep blood was collected using sodium citrate anti­
coagulant, and then centrifuged. The plasma was discarded, 
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and the erythrocytes were washed three times in 0.85 percent 
saline and diluted in 0.85 percent saline to give a 2.5 per­
cent erythrocyte concentration. The lipopolysaccharide anti­
gen was suspended in a small amount of 0.85 percent saline 
and heated to 100° G. for 1 hour. After being cooled, the 
lipopolysaccharide solution was then added to the erythrocyte 
suspension at the rate of 1.5 mg. per ml» of the 2.5 percent 
erythrocyte suspension. The mixture of erythrocytes and 
lipopolysaccharide was incubated at 37° G. for 30 minutes, 
then centrifuged, and washed three times with 0.85 percent 
saline to remove the excess lipopolysaccharide. The modified 
erythrocytes were again resuspended in 0.85 percent saline 
with a 2.5 percent erythrocyte concentration. 
Before the serum samples were tested for specific antibody 
activity, the samples were inactivated for 50 minutes in a 56° 
C. water bath. Twofold serial dilutions were then carried 
out in small test tubes by adding 0.1 ml. of serum to the 
first tube, which contained 0.1 ml. of 0.85 percent saline, 
.mixing, and then transferring 0.25 ml. from the first tube to 
the subsequent tube, which contained 0.25 ml. of saline. Then 
0.25 ml. of the 2.5 percent modified erythrocyte suspension 
were added to each tube. The tubes were then incubated at 
37° C. for 8 hours, and then read grossly by tapping each 
tube and noting whether the erythrocytes were clumped. 
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APPENDIX C 
Procedure for Antibody Titrations for Escherichia 
coll 2A2 and Candida albicans No, 2951 
Serial dilutions of serum in a dilute suspension of bac­
terin specific for each organism corresponding to McFarland 
nephelometer tube number 1 were made. One tenth of a ml. of 
serum was added to 0.9 ml. of bacterin, the two mixed and 
0.5 ml. of the mixture transferred to the second tube. The 
second tube contained 0.5 ml. of bacterin and this was mixed 
with the 0.5 ml. of mixture from the first tube. This process 
was repeated in succeeding tubes. A sufficient number of 
dilutions were made with each serum sample to allow at least 
one negative tube beyond the highest positive dilution. The 
dilution tubes containing the mixture of serum and bacterin 
were then incubated at 37° C. for 24 hours. After incubation 
the dilution tubes were cooled at 5° C. for 24 hours. After 
cooling, each tube was tapped gently and the degree of agglu­
tination was recorded. 
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APPENDIX D 
Source of Organisms 
A strain of Serratla marcescens obtained from the stock 
cultures of the Department of Bacteriology, Iowa State Col­
lege, Ames, Iowa, a strain of Escherichia coll variety neo-
polltins 2A2 isolated from the rectum of a pig at the Swine 
Nutrition Research Farm, Iowa State College, Ames, Iowa and 
classified as above by the classification of Breed et al. 
(1948), and Candida albicans No. 2951 obtained from the stock 
cultures of the Bacteriology Division of the Squibb Institute 
were used in this study. Serratla marcescens was selected be­
cause it is foreign to the intestine of pigs. The Escherichia 
coll variety neopolitins 2A2 and Candida albicans No. 2951 
were selected because some of those concerned in this research 
felt that strains of these two organisms may be responsible 
for baby pig diarrhea, under certain conditions. 
Escherichia coll RB-4 was originally isolated from the 
cecum of a rabbit at the Bacteriology Department, Iowa State 
College, Ames, Iowa. It was agglutinated with 0111:B4 anti­
serum obtained from the Communicable Disease Center, Atlanta, 
C-eorgia. 
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APPENDIX E 
Preparation of Bacterins 
The standardized antigen for Serratla marcescens and 
Escherichia coll variety neopolitins 2A2 were prepared by 
growing pure cultures of each organism on nutrient agar for 
24 hours at 37° C. for the E. coll and at 30° G. for the 
Serratla marcescens. The cell growth was then rinsed off 
the agar with a small quantity of isotonic saline to which 
0.2 percent formalin had been added. Enough cells were added 
to the suspension to give appropriate concentrations corre­
sponding to tube number 1 or tube number 4 on the McFarland 
8 
Nephelometer. These correspond to approximately 3.0 x 10 
cells per ml. for tube 1 and 1.2 x 109 cells per ml. for tube 
4. 
The standardized antigen for the Candida albicans 2951 
and a microscopic count of the cells was used to obtain the 
approximate cellular concentrations of that of the other 
antigens. 
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APPENDIX F 
Original Preparation of Zymosan 
Pillemer, L. and E. E. Ecker. Anticomplementary factor in 
fresh yeast. J. of Biol. Chem. 137:139. 1941 
500 gm. of fresh Fleischmann1s yeast were suspended 
in two liters of 0.5M NagHOP^., boiled for one hour, 
and then cooled. 0.5 gm. of purified trypsin (Wil­
son special trypsin) was added together with a few 
drops of toluene, and the mixture was incubated at 37° 
for 16 days. At the end of this time the mixture was 
negative to protein tests. The supernatant fluid was 
decanted and discarded. Two volumes of 95 percent 
ethyl alcohol were added to the residue; the latter 
was then filtered and washed six times with 94 per­
cent alcohol. The supernatants and washings were 
discarded. The precipitate (Fraction A) was added 
to four liters of warm water, boiled for 30 min­
utes, and allowed to settle; the supernatnat was 
syphoned off. This process was repeated two times. 
The original precipitate (Fraction A) was boiled 
several times with distilled water and centrifuged 
each time while hot, the process being repeated 
until the acid hydrolysis products of the super­
natant liquids failed to reduce Fehling's solution. 
The residue was washed repeatedly with absolute 
alcohol and dried as completely as possible. The 
dried material was then refluxed for three hours 
with absolute alcohol, filtered, and finally dried 
in vacuo. The resultant product was s. fine, almost 
white, hygroscopic powder, which was insoluble in 
hot water, organic solvents, and cold alkali. The 
yield was about two percent. Chemical analysis re­
vealed carbohydrate 94 percent, nitrogen 1.78, mag­
nesium 2.43, phosphorus 0.4. This fraction was 
labeled the "insoluble fraction", and it proved to 
be the agent responsible for the inactivitation of 
the third component. 
This material was further fractionated by the fol­
lowing procedure. 
Two gm. of insoluble fraction were added to 100 cc. 
of cold 1 N HC1. and the mixture was kept overnight 
in the refrigerator at a temperature of about 3°T 
Ill 
The suspension was then centrifuged, and the super­
natant, which contained the magnesium-phosphorus 
complex, was decanted. The precipitate (Fraction B) 
was added to one liter of warm water, boiled for one 
hour, and centrifuged while hot. The undissolved 
material was boiled again several times with dis­
tilled water, and processed by a method similar to 
that used in the preparation of the original in­
soluble fraction. The product was designated as 
Fraction C, and contained 0.54 percent nitrogen. 
All of the insoluble fractions were stored in 
vacuo, since, upon long exposure to air, they 
adsorbed moisture and changes occurred so that 
they no longer inactivated the third component. 
When such changes occurred, the original activity 
was restored by refluxing the material again with 
absolute alcohol. 
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APPENDIX G 
Experimental Rations 
Table 6. Composition of the prestarter ration 
Ingredients8, Amounts 
Ground yellow corn 18.76 
Cane sugar 15.00 
Ground oat groats 15.00 
Solvent soybean oil meal (50$ protein) 1.19 
Dried skimmilk (low heat, spray dried) 40.00 
Fish solubles (condensed) 2.50 
Stabilized lard 2.00 
Dried beet pulp 2.00 
Calcium carbonate 0.10 
Dicalcium phosphate 0.75 
Iodized salt 0.50 
Trace mineral mix^ 0.20 
Vitamin-antibiotic premix (soybean meal carrier) 2.00 
Total (lbs.) 100.00 
aThe calculated analysis of this ration is shown in 
Table 11. 
&The composition of the trace mineral mix is shown in 
Table 10. 
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Table 7. Composition of the starter ration 
Ingredients9- Amounts 
Ground yellow corn 19 .95 
Cane sugar 15 .00 
Ground oat groats 15 .00 
Dried whey (sweet) 10 .00 
Solvent soyben oil meal (50$ protein) 19 .00 
Dried skimmilk (low heat, spray dried) 10 o
 
o
 
Fish solubles (condensed) 2 .50 
Stabilized lard 2 
o
 
o
 
Dried beet pulp 2 
o
 
o
 
Calcium carbonate 0 .25 
Dicalcium phosphate 1 .60 
Iodized salt 0 .50 
Trace mineral mix*3 0 .20 
Vitamin-antibiotic premix (soybean meal carrier) 2 .00 
Total (lbs.) 100.00 
sThe calculated analysis of this ration is shown in 
Table 11. 
^The composition of the trace mineral mix is  shown in 
Table 10. 
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Table 8. Composition of the grower rations 
Amounts 
Ingredients A B 
Ground yellow corn 71.65 74.39 
Dried whey (sweet) 2.50 
Solvent soybean oil meal (50$ protein) 23.80 16.24 
Meat and bone scraps (50$ protein) 2.50 
Calcium carbonate 0.90 0.32 
Dicalcium phosphate 0.95 1.40 
Iodized salt 0.50 0.50 
Trace mineral mixb 0.20 0.15 
Vitamin-antibiotic premix 
(soybean meal carrier) 2.00 2.00 
Total (lbs.) 100.00 100.00 
aThe calculated analysis of this ration is shown in 
Table 11. 
^The composition of the trace mineral mix Is shown in 
Table 10. 
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Table 9. Composition of the lactation ration 
Ingredients Amounts 
Ground yellow corn 40.00 
Ground oats 20.00 
Dried beet pulp 5.00 
Solvent soybean oil meal (50$ protein) 10.00 
Meat and bone scraps (50$ protein) 5.00 
Dried whey (sweet) 5.00 
Dehydrated alfalfa meal 10.00 
Fish solubles (condensed) 2.50 
Dicalcium phosphate 0.80 
Iodized salt 0.50 
Trace mineral mix*3 0.20 
Vitamin-antibiotic premix (corn carrier) 1.00 
Total (lbs.) 100.00 
aThe calculated analysis of this ration is shown in 
Table 11. 
bThe composition of the trace mineral mix is shown in 
Table 10. 
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Table 10. Contents of the trace mineral mix 
Amounts in parts per million 
Contributed to diet Contributed to diet 
Element when added at 0.15$ when added at 0.20$ 
Iron 105.6 140.8 
Copper 7.2 9.6 
Cobalt 2.4 3.2 
Zinc 122.4 163.2 
Manganese 85.2 113.6 
Potassium 11.2 15.0 
Table 11» Calculated analysis of the rations fed 
I tema 
Prestarter Starter Grower A Grower B Lactation 
Table 6 Table 7 Table 8 Table 8 Table 9 
Protein, % 20.00 20.00 18.00 16-00 16.80 
Calcium, % 0.80 0.80 0.65 0.80 0.98 
Phosphorus, % 0.70 0.70 0. 50 0.71 0.70 
Vitamin A, I.U. 3000.00 3000.00 3000.00 2000.00 7900.00 
Vi tamin Dg, I.U. 500.00 500.00 500,00 400.00 500.00 
Riboflavin, mg. 5.00 5.00 5.00 2. 5 2.6 
Calcium pantothenate, mg. 10.0 10.0 10.0 6.0 9.0 
Niacin, mg. 30.0 30.0 30.0 20.0 20.0 
Choline, mg. 500.0 500.0 500.0 400.0 432.0 
Vitamin Bj_g, meg. 20.0 20.0 2,0.0 10.0 10.0 
Folic acid, meg. 0.25 w ^ — _ 
Penicillin, mg. —  —  —  —  — — — —  5.0 
Neomycin, mg.c 5.0 5.0 5.0 — —  — 
Bacitracin, gm.c 10.0 10,0 10.0 —  —  — —  
Aureomycin, mg. — —  25.00 —  —  
10$ 3-nitro powder, % —  —* — — — 0.025 — — 
Butylated hydroxy toluene, % 0.0125 0.0125 0.0125 — 
aThe vitamins and antibiotics are listed as amounts per pound of ration. 
^The vitamins and antibiotics listed from vitamin and below are the 
amounts added per pound of ration and do not include that present in the natural 
ingredients. 
°These two antibiotics were not included in the basal ration in Experiment 
896, however, they were included in all other experiments. 
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APPENDIX H 
Statistical Treatment 
Table 12. Experiment 901 - analysis of covariance of the 
hemagglutination titers with respect to weeks 
after birth 
Source of variation 
Degrees of 
freedom 
Mean 
square 
Total 48 0.8408 
Treatment (time interval) 6 6.0177 
Linear regression ^ 1 35.8891 
Remainder 5 0.0435 
Replications (litters) 6 0.2425 
Error 36 0.0778 
^Difference significant at P = 0.01 or less 
Table 13. Experiment 937A and 937B - analysis of variance 
plan and mean squares for total gain and feed per 
pound of gain 
Mean squares 
937A 937B 
Source of 
variation 
Degrees of 
freedom 
Total 
gain 
Feed/lb. 
gain 
Total 
gain 
Feed/lb 
gain 
Total 35 16.51 0.0458 4.7533 0.0572 
Replications 8 40.46 0.0238 6.8568 0.1374 
Treatment 3 2.75 0.0095 1.8032 0.0168 
Error 24 10.25 0.0576 4.4209 0.0354 
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Table 14. Experiments 93?A and 937B - analysis of variance 
plan and mean squares of serum antibody titers to 
E. coll and Candida albicans at 5 weeks of age 
Mean squares 
Degrees 93 7A 937B 
Source of 
variation 
of 
freedom E, coll 
Candida 
albicans E. coll 
Candida 
albicans 
Total 35 85.714 1,030.7 739.286 56.578 
Replications 8 68.750 1,716.4 600.000 90.278 
Treatment 3 307.407* 2,777.0% 1,261.667 162.963% 
Error 24 76.157 514,3 716.667 32.046 
^Difference significant at P = 0.05 or less. 
^Difference significant at P = 0.01 or less. 
Table 15. Experiment 896 - analysis of variance plan and mean 
squares for gain, feed efficiency and antibody 
titer to Serratla marcescens 
Mean squares 
Source of 
variation 
Degrees of 
freedom Gain 
Feed/lb. 
gain 
Antibody 
titer 
Total 23 15.08 20.47 8,067 
Replications 3 40.54 46.02 2,022 
Treatments 5 5.86 7.46 30,46?s 
Error 15 13.08 19.70 10,560 
^Difference significant at P -, 0.10 or less. 
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Table 16. Experiment 866 - analysis of variance plan and 
mean squares for gain 
Source of variation 
Degrees of 
freedom 
Mean 
square 
Trial 1 
Total 38 18.6866 
Treatment 1 3.9100 
Error 37 19.0859 
Trial 2 
Total 18 4.4183 
Treatment 1 32.3000* 
Error 17 2.7782 
Trial 3 
Total 20 12.5675 
Treatment 1 28.9700 
Error 19 11.7042 
^Difference significant at P = 0.01 or less. 
Table 1?. Experiment 880 - analysis of variance plan and mean 
squares for gain 
Source of variation 
Degrees of 
freedom 
Mean 
sausre 
Total 
Replications 
Treatments 
Error 
39 
9 
3 
27 
26.4156 
62.2090 
9.2127 
16.3959 
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Table 18. Experiment 912 - analysis 
mean squares for gain and 
of variance plan and 
feed efficiency 
Mean squares 
Degrees of Total Feed/lb. 
Source of variation freedom gain gain 
Total 7 
Replications 3 
Treatment 1 
Error 3 
145.5436 
317.8413 
105.8195a 
13.8795 
0.0169 
0.0295 
0.0276^ 
. 0.0008 
^Difference significant at P = 0.10 or less. 
^Difference significant at P = 0.01 or less. 
Table 19. Experiment 943 - analysis of variance plan and 
mean squares for gain and feed efficiency 
Degrees of 
Source of variation freedom 
Mean squares 
To tal Feed/lb. 
gain gain 
Total 
Replications 
Treatment 
Error 
7 
1 
3 
3 
41.6507 
86.1328 
21.6537 
46.8203 
0.0090 
0.0378 
0.0049 
0.0036 
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Table 20. Experiment 964 - analysis of variance plan and 
mean squares for gain and feed efficiency 
Source of variation 
Degrees of 
freedom 
Mean_ squares 
Feed/lb. Total 
gain gain 
Total 
Replications 
Treatment 
Error 
3 
1 
1 
1 
5.0126 
0.3136 
14.1376 
0.5865 
0.0178 
0.0256 
0.0484 
0.0016 
